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Quantifying risks and interventions that have reduced mortality 
due to diarrhea among children younger than 5 years old: An 
analysis of the Global Burden of Disease study 2017 
GBD 2017 Diarrhea Collaborators 
Abstract 5 
Background. Many countries have shown marked declines in diarrhea disease mortality among 
children under-5, and much of this progress has been associated with programs addressing key 
environmental risks for diarrhea and scaling up interventions to prevent or effectively treat 
acute diarrhea. Yet no study to date has assessed the contribution of a range of risk factors and 
interventions on diarrheal disease mortality across a range of settings and over time. With this 10 
analysis, we provide updated results on diarrhea disease mortality among children under 5 
from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), and 
leverage the study’s comparative risk assessment to quantify trends and effects of risk factors, 
interventions, and broader sociodemographic development on mortality changes from 1990 to 
2017. 15 
Methods. There are three main components of this analysis for GBD 2017. Diarrhea mortality 
was modeled using vital registration and verbal autopsy data in a predictive, Bayesian, 
ensemble modeling tool; and the attribution of risk factors and interventions for diarrhea was 
modeled in a counterfactual framework that combines modeled population-level prevalence of 
the exposure to each risk or intervention with the relative risk of diarrhea given exposure to that 20 
factor. We assessed the relative and absolute change in diarrhea mortality rate between 1990 
and 2017 and used the change in risk factor exposure and socio-demographic status to explain 
differences in the trends of diarrhea mortality among children younger than 5 years. 
Findings. Diarrhea was responsible for an estimated 533,768 deaths (95% Uncertainty Interval 
[UI] 477,162 to 593,145) among children under-5 in 2017 globally, a rate of 78.4 per 100,000 (95% 25 
UI 70.1-87.1). The diarrhea mortality rate ranged between countries by over 685 per 100,000. 
Diarrhea mortality per 100,000 decreased by 69.6% between 1990 and 2017 globally (95% UI 63.1 
to 74.6%). The largest relative decline in diarrhea mortality occurred in Saudi Arabia (98.1% 
decrease, 95% UI 95.9 to 99.1%) while the greatest absolute decline in diarrhea mortality 
occurred in Niger (1,344.2 fewer deaths per 100,000, 95% UI 969.9 to 1,735.1). Among the risk 30 
factors in this study, reductions in exposure to unsafe sanitation (13.3% decrease, 95% UI 11.2 to 
15.5%), childhood wasting (9.9% decrease, 95% UI 9.6 to 10.2%), and low oral rehydration 
solution (ORS) coverage (6.9% decrease, 95% UI 4.8 to 8.4%) were responsible for the largest 
reductions in the diarrhea mortality rate.  
Interpretation. Our findings show that there have been substantial declines in diarrhea 35 
mortality but with variation by country since 1990. Although improvements in socio-
demographic indicators may explain some of these trends, changes in exposure to risk factors, 
particularly childhood growth failure, sanitation, and ORS, appear to be related to the relative 
and absolute rates of decline in diarrhea mortality. The most impactful interventions may vary 
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by country or region but emphasizing interventions to prevent and protect against diarrhea 40 
have reduced diarrhea mortality and scaling up these interventions could avert many 
thousands of deaths due to diarrhea. 
Funding. Bill & Melinda Gates Foundation. 
 
Research in Context 45 
Evidence before this study 
The Global Burden of Disease study (GBD) has produced a series of updates to estimates of 
health loss due to over 300 causes of death and disability, including diarrhea. The GBD study 
produces estimates for 195 countries and territories, both sexes, every age group, and over time. 
There are several other groups that also estimate diarrhea mortality, particularly among 50 
children younger than 5 years, including the World Health Organization/Maternal and Child 
Epidemiology Estimation partnership. Although the estimates vary slightly between GBD 
iterations and compared with other groups’ estimates, one thing that is generally agreed upon 
is that diarrhea mortality among children younger than 5 is decreasing over time. Although 
there has been some effort to report the impact of a range of risk factors for diarrhea mortality 55 
in a cross-sectional way, to our knowledge, no other study has attempted to evaluate changes in 
mortality over time due to demographic changes and changes in risk factor exposure.  
Added value of this study 
Here we report findings from the GBD 2017 study which builds on previous iterations of the 
GBD with additional data and modeling improvements. We use estimates of 12 risk factors or 60 
interventions for diarrhea mortality, produced for the GBD study, to evaluate changes in 
diarrhea mortality among children younger than 5. A major component of the GBD study is 
producing internally consistent and externally comparable estimates for all locations and over 
time, which allows us to identify countries where the diarrhea mortality rate has changed the 
most and to evaluate the contributing risk factors or interventions that impact the mortality rate. 65 
We provide cross-sectional and longitudinal estimates of the reasons of why children are dying 
from diarrhea, how this varies, and where specific interventions may have the greatest impact.  
Implications of all the available evidence 
Diarrhea mortality among children younger than 5 years has declined in many parts of the 
world, particularly due to improvements in safe sanitation, childhood nutrition, and oral 70 
rehydration solution. However, there is variation by country, suggesting that there is no single 
silver bullet to reduce diarrhea mortality. Every country must consider their specific context to 
identify strategies to reduce diarrhea mortality. Our estimates can help provide evidence to do 
so.  
 75 
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Introduction 
Diarrheal diseases (diarrhea) are the second leading infectious cause of mortality, after lower 
respiratory infections, among children younger than 5 years old globally and childhood 80 
mortality due to diarrhea has declined since the 1990s.1–5 Accelerating and maintaining these 
declines is essential to meeting sustainable development goals for under-5 childhood mortality 
and ensuring that children everywhere have the opportunity at a full, healthy life.  
Many countries have shown marked declines in diarrhea mortality among children younger 
than 5, and much of this progress has been associated with programs that address key 85 
environmental risks for diarrhea and scaling up interventions to prevent or treat acute 
diarrhea.3 Several global initiatives have offered guidance on efficient and recommended 
interventions to avert illness and mortality, including the Global Action Plan for Pneumonia 
and Diarrhea.6 These programs have typically categorized interventions into groups that are 
defined by where in the morbidity pathway they occur, including prevention of infection such 90 
as provision of safe water and sanitation, and treatment of disease, such as oral rehydration 
solution.7 Yet no study to date has assessed the contribution of a range of risk factors and 
interventions on diarrhea mortality across settings and over time.  
We have previously shown a strong relationship between the socio-demographic level and 
diarrhea mortality2,8 but that does not necessarily translate to actionable evidence of 95 
interventions to prioritize to reduce health-loss associated with diarrhea.  Understanding why 
some countries have seen more progress than others would provide such evidence and give a 
targeted roadmap for accelerating declines in diarrhea mortality. The Global Burden of Disease 
study 2017 (GBD) is a systematic, scientific effort to quantify morbidity and mortality, including 
for diarrhea and its risk factors.1,9,10 With this analysis, we provide updated results of estimates 100 
of diarrhea mortality among children younger than 5 and leverage the study’s comparative risk 
assessment to quantify trends and effects of risk factors, interventions, and broader 
sociodemographic development on mortality changes from 1990 to 2017. We use results from 
the GBD 2017 to assess which countries have performed best in reducing under-5 diarrhea 
mortality and compare countries on the basis of mortality rates, exposure to risk factors and 105 
interventions, and the contribution of changes in risk factor exposure on diarrhea mortality.  
Methods 
Detailed methods on the Global Burden of Disease study and on diarrhea estimation in GBD 
have been previously published.1–3,9,10 We describe these methods briefly, focusing on a high-
level description of modeling strategy. More information about diarrhea mortality modeling in 110 
GBD 2017 is provided in the Appendix. Uncertainty in the diarrhea estimates are maintained 
through the modelling process using 1000 draws and are reflected as 2·5th and 97·5th percentiles 
of the posterior distribution. In compliance with the Guidelines for Accurate and Transparent 
Health Estimates Reporting (GATHER),11 data and code for the GBD 2017 cycle are publicly 
available (https://ghdx.healthdata.org/).  115 
There are four main components of the analysis that we share here: 1) diarrhea mortality 
estimation; 2) diarrhea morbidity estimation; 3) diarrhea risk factor and intervention estimation; 
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and 4) the application of these results to evaluate changes in diarrhea mortality between 1990 
and 2017. 
Mortality. Most causes of death in the GBD 2017, including diarrhea, are modeled in the Cause 120 
of Death Ensemble model (CODEm).1,12 This statistical tool is designed to create a wide variety 
of models using a covariate selection algorithm and then to weight these models based on their 
out-of-sample predictive validity. These models are combined into an ensemble that predicts 
diarrhea mortality by age, sex, year, and geography from 1980 to 2017. The model for diarrhea 
uses vital registration, demographic surveillance, and verbal autopsy data. Covariates include 125 
childhood undernutrition, safe water and sanitation, the Socio-demographic Index (SDI), and 
maternal education among others.1 SDI is a composite measure of development that accounts 
for fertility, education, and income and we have previously shown that it is associated with 
many population health indicators, including diarrhea mortality.2 
Risk factors. Risk factors in the GBD 2017 study are causally related to diarrhea incidence or 130 
mortality.10 There are 12 risk factors or interventions for diarrhea reported in this manuscript 
and estimated in GBD 2017 (Table 1). In general, risk factors are part of a comparative risk 
assessment framework that involves a counterfactual approach to quantify the level of exposure 
to the risk factor in a population and the relative risk of diarrhea given exposure. Typically, the 
exposure in a population is modeled based on surveys and scientific literature and the risk of 135 
diarrhea is from published meta-analyses. More information on the modeling strategy for the 
risk factors can be found in the Appendix (pages 7-45). We also used existing aggregate risk 
factors for 1) childhood growth failure and 2) unsafe water, sanitation, and hygiene.10  
Risk factors are counter-factual and estimated independently. For these reasons, the sum of risk 
factor attributable fractions is not equal to 100% in a given population and may be more or less, 140 
depending on the population-level exposure to each factor. In other words, in this 
counterfactual approach, there are multiple potential ways to avert an episode of diarrhea or 
prevent a diarrhea death. For example, a child who dies from diarrhea may have lacked 
adequate nutrition or safe water but access to either may have saved her life, even without 
access to the other.  145 
Analysis of temporal trends. The last component is the application of these results to space and 
time patterns. The primary outcome of interest is the diarrhea mortality rate per 100,000 in 1990 
and 2017. We calculated the absolute change in mortality rate as the difference between rates 
between 1990 and 2017. We calculated the relative percent change in mortality rate in 2017 
compared to 1990. We fit a log-normal regression using SDI to predict the expected change in 150 
diarrheal mortality rate per unit increase in SDI. This rate was considered the baseline change in 
diarrheal mortality that is explained by changes in SDI. 
To assess the effect of changes for each risk factor among children under 5, we took advantage 
of the counterfactual definition of risk factor burden such that the diarrhea mortality rate due to 
each risk factor was equivalent to the reduction expected given complete absence of the risk 155 
factor. We categorized risk factors for diarrhea mortality into two groups based on their 
biological mechanism of risk: prevention and protection. Prevention associated risks are those 
that increase the probability of becoming an incident episode of diarrhea and include lack of 
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rotavirus vaccine, no handwashing with soap, unsafe water, unsafe sanitation, and dietary zinc 
deficiency. Protection associated risks are those that increase the likelihood of mortality among 160 
children with diarrhea and include suboptimal breastfeeding, not receiving oral rehydration 
solution, low birth weight and short gestation, childhood stunting, childhood underweight, 
childhood wasting, and vitamin A deficiency (Table 1). We performed a decomposition of the 
effect of the change in exposure to each risk factor on the diarrhea mortality rate between 1990 
and 2017, accounting for the independent effects of population growth, population ageing, and 165 
other drivers of diarrhea mortality. This process has been described in detail elsewhere.8,10  
Results 
In 2017, diarrhea was responsible for an estimated 533,768 deaths (95% UI 477,162 to 593,145) 
among children under-5, globally (Table 2), accounting for 9.9% of all deaths among children 
younger than 5 (95% UI 8.9 to 10.9%). Together, India (102,678 deaths, 95% UI 87,608 to 118,510) 170 
and Nigeria (104,267 deaths, 95% UI 75,975 to 139,594) accounted for more than a third of all 
diarrhea deaths (Table 2). The mortality rate among children younger than 5 was 78.4 per 
100,000 (95% UI 70.1 to 87.1) globally and ranged from 0.09 (95% UI 0.07 to 0.13) in Singapore to 
685.8 in the Central African Republic (95% UI 385.7 to 1083.0; Figures 1 and 2A). The regions 
with the highest diarrhea mortality rates were Western sub-Saharan Africa (269.3 per 100,000, 175 
95% UI 219.1 to 328.9) and Central sub-Saharan Africa (176.1, 95% UI 130.6 to 233.9; Table 2, 
Figure 2A).  
Diarrhea mortality per 100,000 decreased by 69.6% between 1990 and 2017 globally (95% UI 63.1 
to 74.6%, Table 2, Figure 1). The greatest relative decline in diarrhea mortality occurred in 
Saudi Arabia (98.1% decrease, 95% UI 95.9 to 99.1%) from 77.1 per 100,000 (95% UI 47.1 to 122.1) 180 
to 1.46 per 100,000 (95% UI 0.79 to 2.58; Table 2, Figure 1). Diarrhea mortality increased in 25 
countries (Figure 2B) but the absolute change in mortality rate in the locations where the 
mortality rate increased tended to be small during this time (Table 2, Figures 1 and 2C). The 
greatest absolute decline in diarrhea mortality occurred in Niger where mortality decreased 
1,344.2 deaths per 100,000 (95% UI 969.9 to 1,735.1) between 1990 and 2017, from 1731.2 per 185 
100,000 (95% UI 1223.8 to 2290.9) in 1990 to 387.8 per 100,000 (95% UI 253.9 to 555.9) in 2017 
(Table 2, Figures 1 and 2C). At the global level, diarrhea incidence declined by 7.2% (95% UI 5.5 
to 8.1%) between 1990-2017, from 1.75 episodes per child-year (95% UI 1.48 to 2.07) in 1990 to 
1.63 episodes per child-year (1.36 to 1.96) in 2017 (data not shown, incidence results available 
at GBD Compare).  190 
Nine countries had mortality rates above the global median rate in 1990 and below the global 
median rate in 2017 (Armenia, China, Iran, Jamaica, Kazakhstan, Macedonia, Saudi Arabia, 
Turkey, and Uzbekistan). These countries tended to experience dramatic increases in SDI levels 
during this time. Diarrhea mortality decreased by 98.1% (95% UI 95.9 to 99.1) in Saudi Arabia as 
reported above, by 98.0% (95% UI 85.5 to 96.5%) in Turkey (127.5 per 100,000 [95% UI 88.1 to 195 
181.5] to 2.6 per 100,000 [95% UI 1.7 to 3.7])]), and by 95.5% (95% UI 94.6 to 96.4%) in China 
(from 65.0 per 100,000 [95% UI 56.3 to 75.9] to 2.9 per 100,000 [95% UI 2.5 to 3.4]). Some of these 
countries had diarrhea mortality rates much lower than expected based on SDI. For example, 
the ratio of observed to expected mortality rates in Armenia (0.17) and Macedonia (0.12) were 
among the three lowest globally suggesting the mortality rate in these countries is much lower 200 
   
 
6 
 
than expected based on SDI (Figure 2D). In contrast, the ratio of observed to expected mortality 
in China (0.83) and Saudi Arabia (1.03) were closer to 1, suggesting a correlation in mortality 
and SDI in these locations. The observed mortality was much greater than expected based on 
SDI in some high-income locations (Canada [18.2] and Austria [12.4]) as well as low-income 
locations (Central African Republic [5.8] and Sudan [4.7]; Figure 2D).   205 
The risk factors included in GBD 2017 for diarrhea among children under-5 accounted for 99.4% 
(95% UI 98.7 to 99.8) of diarrhea deaths in 2017 (Table 2 and Figure 3). Full use of the rotavirus 
vaccine may prevent an estimated 22.0% of diarrhea deaths (95% UI 16.7 to 27.9%) and 
providing safe water, sanitation, and hygiene (WASH) could avert 94.8% of deaths (95% UI 81.3 
to 98.9%; Table 2 and Figure 3) at the global level. Risk factors related to poor childhood 210 
nutrition including growth failure and micronutrient deficiencies were responsible for 89.6% 
(95% UI 77.6 to 94.7%) of diarrhea deaths in 2017 and full coverage of oral rehydration solution 
(ORS) could prevent 57.7% of diarrhea deaths in 2017 (95% UI 39.9 to 70.8%; Table 2 and Figure 
3A). Poor childhood nutrition and unsafe WASH were attributed to a comparable fraction of 
deaths in most GBD super-regions with the exception of the High-income super-region where 215 
unsafe WASH was responsible for only 20.2% of deaths (95% UI 8.5 to 34.6%; Table 2 and 
Figure 3A).  
A decomposition analysis of the percent change in diarrhea mortality between 1990 and 2017 
due to changes in risk factor attribution is shown in Figure 4. Globally, unsafe sanitation (13.3% 
decrease, 95% UI 11.2 to 15.5%), childhood wasting (9.9% decrease, 95% UI 9.6 to 10.2%), and 220 
low ORS coverage (6.9% decrease, 95% UI 4.8 to 8.4%) were responsible for the greatest 
reductions in the diarrhea mortality rate (Figure 4).  
Among the quintile of countries where the absolute decrease in diarrhea mortality rate was 
largest, improvements in risk factors associated with undernutrition were correlated with the 
largest declines in diarrhea mortality, including improvements in childhood wasting (19.0% 225 
decrease), childhood stunting (5.9% mean decrease), childhood underweight (5.5% decrease), 
vitamin A deficiency (9.4% mean decrease), and zinc deficiency (1.6% decreased attribution; 
Figure 4E). Expanded ORS coverage reduced diarrhea mortality by 7.1% on average in these 
countries (Figure 4E). The fastest improvements in childhood wasting were seen in Laos (55.2% 
decrease, 95% UI 50.2 to 52.4%) and Angola (53.9% decrease, 95% UI 45.5 to 59.1%; Figure 4E). 230 
Many countries in this quintile of diarrhea mortality decline, including Sierra Leone (24.5% 
decrease, 95% UI 16.9 to 29.8%), greatly reduced diarrhea mortality by expanding ORS coverage 
(Figure 4E). Rotavirus vaccine reduced diarrhea mortality by substantial amounts among some 
countries that have introduced the vaccine such as 39.2% in Burkina Faso (95% UI 22.4 to 73.7%) 
and by 34.3% in Togo (95% UI 19.3 to 63.2%; Figure 4E). The countries with the greatest 235 
absolute decline in diarrhea mortality rate did not frequently have much of this reduction 
explained by water, sanitation, and hygiene with some exceptions in Equatorial Guinea and 
Egypt (Figure 4E).  
Countries in the fourth quintile of the absolute change in diarrhea mortality rate tended to have 
more decline explained by WASH risks such as a 28.0% decrease (95% UI 25.7 to 29.7%) in 240 
diarrhea mortality due to sanitation in Indonesia and a 21.8% reduction in India (95% UI 18.9 to 
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23.8%); a 39.2% (95% UI 27.8 to 50.2%) decline due to unsafe water in Botswana, and a 10.7% 
(95% UI 4.8 to 16.2%) decline due to handwashing in Bhutan (Figure 4D). The mean change in 
diarrhea mortality in these countries was more evenly explained by childhood growth failure, 
micronutrition, and WASH risk factors than for countries in the third (Figure 4C) and second 245 
(Figure 4B) quintiles for reduction in diarrhea mortality. China and Saudi Arabia, two of three 
countries with the largest relative decline in diarrhea mortality rate, were in the third quintile in 
absolute decline. A substantial amount of the decline in China was driven by improvements in 
handwashing (6.8%, 95% UI 3.0 to 10.9%), unsafe sanitation (20.6%, 95% UI 19.4 to 21.0%), and 
unsafe water (22.4%, 95% UI 14.2 to 29.8%) (Figure 4C). Countries in the first quintile with the 250 
smallest absolute change in diarrhea mortality tended to be countries in the high-income GBD 
super-region. The mortality rate increased due to greater prevalence of low birth weight and 
short gestational age in this quintile and by as much as 8.7% (95% UI 8.3 to 10.3%) in Singapore 
(Figure 4A).  Although the Central African Republic and Zimbabwe reduced diarrhea mortality 
due to improvements in suboptimal breastfeeding, vitamin A deficiency, and low rotavirus 255 
vaccine coverage, the mortality rate increased in these two locations (6.1 per 100,000 increase in 
Zimbabwe and 241.4 per 100,000 increase in the Central African Republic; Table 2 and Figure 
4A).  
Discussion 
Diarrhea mortality among children younger than 5 is largely preventable with existing 260 
interventions that reduce exposure to pathogens and reduce the risk of mortality. Our estimates 
from this and previous iterations of the GBD study have consistently shown that diarrhea is one 
of the leading causes of death in this age group.2,3 There is reason to be optimistic about the 
observed decline in mortality. This trend should not lull public health officials, policy makers, 
and funding agencies into a sense that persistence of such declines is inevitable, but rather 265 
should press all actors into asking why the pace of decline has been unequal across countries. 
The analyses presented here attempt to answer some of those most important questions.  
The SDI increased in every country between 1990 and 2017.1 The greatest increase in SDI 
between 1990 and 2017 occurred in Equatorial Guinea, a country where diarrhea mortality 
decreased by more than 550 deaths per 100,000 during that time period. However, the two 270 
countries with the greatest absolute decline in diarrhea mortality rates, Niger and Liberia, had 
increases in SDI that were smaller than the global average.1 We have previously shown that the 
SDI is a strong predictor of diarrhea mortality, but there are locations where difference between 
the mortality rate and the rate predicted on the basis of changes in SDI is large (Figure 2D).2 An 
important contrast becomes apparent as the countries with the greatest relative decline in 275 
diarrhea mortality, like China, Turkey, and Saudi Arabia appear to be correlated with increases 
in SDI while the countries with the greatest absolute decline in diarrhea mortality have 
exceeded declines predicted by SDI. Increasing development is related to greater ability for 
countries to build and maintain integrative surveillance and treatment programs. For example, 
starting in the early 1990s, China implemented a series of national programs to reduce under-5 280 
mortality, including the Program for Control of Diarrheal Diseases that focused on surveillance, 
health education, training, and access to healthcare for all counties, cities, and provinces with 
emphasis on rural areas.13  
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Regardless of distinguishing between relative and absolute change, countries with the largest 
declines in diarrhea mortality rate tended to have large reductions in childhood underweight 285 
and stunting attribution. There have been substantial reductions in childhood growth failure 
from 1990 to 2017 but with stubborn subnational variation.14 Improving nutritional status of 
children is the single most important intervention to prevent infectious disease mortality. To a 
smaller extent, micronutrient deficiencies like vitamin A and zinc have improved in countries 
with either the fastest relative or absolute change. Childhood growth failure, including stunting, 290 
underweight, and wasting, appear to have a nearly linear relationship with SDI.10 The dietary 
zinc deficiency risk factor reported in this manuscript is distinct from zinc therapy which has 
been shown to substantially reduce diarrhea duration and possibly mortality among children.15 
We have previously shown that diarrheal episodes among children are associated with 
impaired growth and accounting for growth failure may increase the overall burden of diarrhea 295 
by 40%.16,17 Given the range of additional health outcomes,18 proven efficacy,19 and cost 
effectiveness; nutritional interventions should not be overlooked when considering child 
vulnerability to diarrheal diseases.20 
In recent years, researchers, policy makers, and clinicians have espoused the biologically 
plausible idea that reducing environmental contamination through WASH might be key to 300 
tackling the persistent challenge of childhood diarrhea and stunting. However, two large trials 
have reported no effect of drinking water, sanitation, and hygiene (WASH) interventions on 
linear child growth and showed only limited benefit for childhood diarrhea. Several studies 
investigating improvements in safe water and sanitation, found little improvement in diarrhea 
incidence or childhood growth.19,21 While these studies focused on family or neighborhood level 305 
interventions, some evidence points to community-level contamination of water sources even 
when some members of the community are using safe water and sanitation. Provision of 
universal safe water and sanitation requires substantial infrastructural development which may 
not be feasible in some locations22,23 It may be that in the absence of near universal coverage, 
community-level contamination persists even when some members are using safe water and 310 
sanitation.19 A recent report concluded that many countries are not on pace to meet universal 
access to safe water and sanitation, markers introduced in the Sustainable Development Goals.24 
Poor access to safe water and sanitation persists particularly among rural and poor populations. 
This study, along with other previous studies, suggest that a more comprehensive, community-
level approach to improving the environment might be necessary to influence child growth.25 315 
Sanitation had the greatest magnitude change in diarrhea mortality among all risk factors 
(13.3% decrease, 95% UI 11.2 to 15.5%), but this change appeared to be greatest in geographies 
at middle values of SDI (0.4 to 0.6).10 Countries with the greatest relative change in diarrhea 
mortality, such as China, Turkey, and Saudi Arabia are examples of areas with dramatic 
reductions due to unsafe WASH. This was not typically true among countries with the fastest 320 
absolute reduction in diarrhea mortality, where the change in attribution for the WASH risks 
were frequently in the slowest two quintiles of change among all countries (Figure 4E).   
Many countries are not near the range of SDI where water and sanitation are likely to improve 
rapidly. Countries at the lower range of SDI that experience the greatest declines in absolute 
mortality rates tended to succeed at reducing attribution to risks that act at the individual level. 325 
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Some of the countries with the largest absolute declines in diarrhea mortality rates, like Niger, 
Nigeria, Sierra Leone, and Somalia, had greater than a 15% reduction in diarrhea mortality due 
to increased ORS coverage. Treatment with ORS, or with recommended home fluids, is 
inexpensive and effective, perhaps explaining why ORS decreased mortality in locations with 
relatively limited change in SDI.  Oral rehydration solution may prevent 93% of diarrhea 330 
deaths,26 but appropriate use remains low in many locations, perhaps due to perceptions that it 
is a medication and must be prescribed by healthcare workers, due to adherence of treatment, 
and due to potential competing treatments, including antibiotics, that are viewed positively as 
Western medicine.27  
Globally, 34.7% of under-5 diarrhea deaths were caused by rotavirus. Existing rotavirus 335 
vaccines prevented about 30,000 deaths in 2016.28 Some of the poorest countries are eligible for 
Gavi support in funding rotavirus vaccine use but have not introduced the vaccine, such as the 
Democratic Republic of the Congo, Nigeria, Chad, and South Sudan.29 These countries also had 
slower reductions in diarrhea mortality than neighboring countries that did introduce the 
vaccine, such as Rwanda, Niger, and Sudan. Countries in Latin America and the Caribbean 340 
tended to be early adopters of the rotavirus vaccine and several countries, like Brazil (11.1% 
decrease), Mexico (12.7% decrease), and Peru (14.5% decrease) have substantially reduced 
diarrhea mortality due to rotavirus. There remains some uncertainty about the future of the 
rotavirus vaccine in high-middle SDI countries that have or will soon transition from being 
Gavi-eligible. Introduction and coverage of the rotavirus vaccine, particularly among high-345 
mortality countries, can avert a substantial amount of the 34.7% of diarrhea deaths attributable 
to rotavirus. 
Limitations. There are a number of limitations in this study. Our estimates are dependent on 
data availability which tends to be scarce, particularly among countries with high expected 
mortality in sub-Saharan Africa. Detailed, reliable, and timely disease burden data are needed 350 
for countries to make informed decisions about health policy and interventions. Global burden 
estimates attempt to fill some of these gaps but exist with substantial uncertainty which we 
have attempted to report consistently and uncertainty is propagated through our modeling 
process. Many of the covariates used in the mortality modeling are also inputs into the risk 
factor attribution as estimates of population-level exposure to those risks. Although we have 355 
quantified ORS treatment for diarrhea, we do not explicitly account for healthcare seeking 
behaviors, primary healthcare availability, and other potential treatments like therapeutic zinc 
and antibiotic use. The comparative risk assessment framework used for risk factors in the GBD 
study estimates risk factors independently. While this is essential for understanding the 
counterfactual disease burden associated with a risk, it means that we are unable to assess the 360 
potential of combined intervention strategies, such as those that target reductions in childhood 
underweight through breastfeeding promotion, and such intervention packages are likely to be 
very effective at reducing disease burden.30 We also know that there can be substantial overlap 
in exposure to risk factors such that an individual child may be both exposed to unsafe water 
and unvaccinated against rotavirus. While we do not account for covariance in all risk factors, 365 
our approach does allow for the intuitive, actionable interpretation that eliminating exposure to 
any attributable risk is sufficient to avert a diarrhea death.   
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Evaluating trends and disease burden on the national level can mask subnational variation that 
exists because of different risk factor exposure, access to healthcare, or other factors. We have 
shown that childhood growth failure,14 diarrhea mortality,5 and under-5 mortality4 are all 370 
geographically heterogeneous between and within countries in Africa. This analysis is from a 
population level which may hide individual exposures and behaviors. Future work evaluating 
risks and trends at fine geographical or individual levels, and including correlations between 
risks at this level, could better inform targeting of resources for interventions.    
This study provides a clear and actionable path for reducing diarrhea mortality among children 375 
younger than 5 but this path is likely to differ depending on location. Provision of ORS for 
diarrheal episodes and the rotavirus vaccine have contributed to declines in even the poorest 
locations while the provision of universal access to safe water and sanitation may require 
substantial infrastructural developments. While less beneficial than some other interventions, 
vitamin A and zinc supplementation should be considered an essential part of routine 380 
childhood healthcare. Continuing to reduce diarrhea mortality among children younger than 5 
requires focused effort and intention. Assuming instead that these declines are inevitable, 
relying on the improvements expected with economic development is not enough, children are 
dying from diarrhea today.  
 385 
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Figure 1. The diarrhea mortality rate among children younger than 5 by country. The colors indicate the GBD super region and the 
uncertainty around the mortality rate estimate in 2017 while the gray points and error bars mark the mortality rate in 1990. Countries 
are ordered from left to right in order of mortality rated in 2017. The horizontal dotted line indicates the median mortality rate in 
1990 and the dashed horizontal line indicates the median mortality rate in 2017. The y-axis is plotted in log 10 transformation.    
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Figure 2. Maps expressing the diarrhea mortality rate per 100,000 among children younger 
than 5 in 2017. A) Diarrhea mortality rate per 100,000 in 2017 among children under-5, B) The 
relative percent difference in diarrhea mortality rate between 2017 and 1990, C) Absolute 
difference between the diarrhea mortality rate per 100,000 in 2017 among children younger than 
5 and D) The ratio between the observed and predicted diarrhea mortality rate per 100,000 
based on the observed change in SDI between 1990 and 2017. Countries with values below 1 in 
panel D indicate that the estimated diarrhea mortality rate is lower than expected based on 
trends expected based on the relationship between the change in SDI and diarrhea mortality 
while values greater than 1 indicate that the estimated mortality rate is greater than expected 
based on the change in SDI.  
 
A) Diarrhea mortality rate per 100,000 in 2017. 
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B) The relative percent different in diarrhea mortality rate between 1990 and 2017 
 
C) The absolute difference between diarrhea mortality rate between 1990 and 2017 per 
100,000. 
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D) Ratio of Observed to Expected mortality rate in 2017 based on the relationship between 
mortality and SDI. 
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Figure 3. Bar charts for the aggregated attributable fractions for diarrheal risk factors among 
children younger than 5 years by GBD super region in 2017. In the comparative risk factors 
framework used in GBD 2017, risk factors are counterfactual and can overlap such that a single 
risk may be sufficient to cause a diarrhea death but is not necessary. Therefore, although the 
Total risk attribution cannot exceed 1, there could be overlap between rotavirus Vaccine, ORS 
Treatment, Nutrition or WASH associated risk factors at the population level such that 
eliminating exposure to one would avert a diarrhea death.  
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Figure 4. The percent change in the diarrhea mortality rate 1990 and 2017 attributable to 
changes in risk factor exposure by country, grouped in quintiles of the attributable change in 
mortality rate during the same time period. Values in the tiles represent the percent reduction 
in diarrhea mortality between 1990 and 2017 attributable to changes in risk factor exposure. The 
Global row represents the value among all countries and the Country grouping row represents 
the mean value among countries in each panel. Solid, thick vertical lines separate types of risks 
or interventions, grouped by nutritional, interventions, then WASH. The panels represent the 
ordered quintile of the absolute change in diarrhea mortality rate between 1990 and 2017 
(difference in rates between 1990 and 2017) starting with the greatest relative decline (A) and 
ending with the smallest relative change (E). The colors of the tiles indicate the quintile for the 
attributable change in mortality due to each risk factor among all countries, ranging from teal 
blue (80-100th percentile of the change in risk attribution) to magenta red (0-20th percentile of 
change in risk attribution).   
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Table 1. Definitions for risk factors and interventions used in this analysis. More information on each risk factor or intervention is 
provided in the Appendix, including input data and modeling strategy.  
Type Risk Factor Definition Modeled Values Interpretation 
Prevention Handwashing 
The proportion of the population that 
does not have access to a handwashing 
station with available soap and water. 
The prevalence of the availability of a 
handwashing station with soap and water.  
The provision of a handwashing station with 
soap reduces the exposure to fecal material. 
Prevention 
Low 
Rotavirus 
Vaccine 
Coverage 
The proportion of children that are not 
vaccinated against rotavirus 
The prevalence of children receiving a full 
course of rotavirus vaccine. 
Not receiving the rotavirus vaccine puts 
children younger than 5 at an increased risk 
of dying from rotavirus diarrhea 
Prevention Unsafe sanitation 
The proportion of the population that 
does not have access to a sanitation 
facility with a sewer connection. 
The prevalence of unimproved sanitation 
use, the prevalence of improved sanitation 
facilities without a sewer connection or 
septic tank, the prevalence of toilet facilities 
with a sewer connection or septic tank. 
Unsafe sanitation has three definitions based 
on the type of facilities in a population. 
Improved and unimproved facilities are 
based on the Joint Monitoring Programme 
definitions for sanitation.  
Prevention Unsafe water 
The proportion of the population that 
does not use high quality piped water 
that has been boiled or filtered before 
drinking. 
The prevalence of 1) unimproved water use 
without household water treatment (HWT), 
2) unimproved water source with chlorine 
or solar purification, 3) unimproved water 
source with boiling or filtration, 4) 
Improved, non-piped water source without 
HWT, 5) Improved, non-piped water source 
with chlorine or solar purification, 6) 
Improved, non-piped water source with 
boiling or filtration, 7) Piped water source 
without HWT, 8) Piped water source with 
chlorine or solar purification, 9) Piped water 
source with boiling or filtration, 10) High 
quality piped water. 
Unsafe water has several categorical 
definitions that have different relative risks 
for diarrhea. The definitions for improved 
and unimproved are from the Joint 
Monitoring Programme for water and 
sanitation. For example, unimproved and 
untreated water has the highest risk of 
diarrhea while improved, untreated water 
has a lower, but still existent, risk for 
diarrhea. The prevalence of each of these 
types of water are modeled for every 
population. 
Prevention Zinc deficiency 
Consumption of less than 2.5 
milligrams of dietary zinc per day 
The prevalence of children who do not 
receive sufficient dietary zinc. 
The low consumption of zinc puts children 
at elevated risks for mortality due to 
diarrhea.  
Protection Childhood stunting 
Proportion of children younger than 5 
years that are less than the WHO 2006 
growth standard for height-for-age 
based on z-scores from that standard. 
The prevalence of mild (<-1 z score), 
moderate (-1 to -2 z scores), and severe 
Prevalence of mild, moderate, and severe 
stunting. 
Children who are short for their age, based 
on international growth standards, have a 
greater risk of dying from diarrhea than 
children who are not. Relative risks for 
diarrhea mortality by mild, moderate, and 
severe stunting are used in this analysis as 
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(>-3 z-scores) were estimated for each 
population.  
are modeled prevalence estimates for each of 
the stunting categories.  
Protection Childhood underweight 
Proportion of children younger than 5 
years that are less than the WHO 2006 
growth standard for weight-for-age 
based on z-scores from that standard. 
The prevalence of mild (<-1 z score), 
moderate (-1 to -2 z scores), and severe 
(>-3 z-scores) were estimated for each 
population.  
Prevalence of mild, moderate, and severe 
underweight. 
Children who are low body weight for their 
age, based on international growth 
standards, have a greater risk of dying from 
diarrhea than children who are not. Relative 
risks for diarrhea mortality by mild, 
moderate, and severe underweight are used 
in this analysis as are modeled prevalence 
estimates for each of the underweight 
categories.  
Protection Childhood wasting 
Proportion of children younger than 5 
years that are less than the WHO 2006 
growth standard for weight-for-height 
based on z-scores from that standard. 
The prevalence of mild (<-1 z score), 
moderate (-1 to -2 z scores), and severe 
(>-3 z-scores) were estimated for each 
population.  
Prevalence of mild, moderate, and severe 
wasting. 
Children who are low weight for their 
height, based on international growth 
standards, have a greater risk of dying from 
diarrhea than children who are not. Relative 
risks for diarrhea mortality by mild, 
moderate, and severe wasting are used in 
this analysis as are modeled prevalence 
estimates for each of the wasting categories.  
Protection 
Low birth 
weight and 
short 
gestation 
A joint estimation of the prevalence of 
birth weight and gestational age below 
the minimum risk exposure level for 
birth weight and gestational age (<4000 
grams and <38 weeks of gestation). 
Jointly estimated prevalence of low weight 
and short gestational period, measured in a 
matrix of 500-gram birth weight and 2-week 
gestational periods. 
The prevalence of low birth weight and 
short gestation period are modeled jointly. 
The prevalence for each category of birth 
weight, in 500 gram bins, and short 
gestation, in 2 week bins, represents the 
proportion of children in a population that 
were born prematurely.  
Protection 
Low Oral 
Rehydration 
Solution 
Coverage 
The proportion of children with 
diarrhea that did not receive oral 
rehydration solution or recommended 
home fluids 
The prevalence of children with diarrhea 
that were treated with oral rehydration 
solution or with recommended home fluids. 
Not receiving oral rehydration solution or 
recommended home fluids puts children 
with diarrhea at an increased risk of death. 
Protection Suboptimal Breastfeeding 
Suboptimal breastfeeding is either non-
exclusive breastfeeding or discontinued 
breastfeeding. Non-exclusive 
breastfeeding is the proportion of 
children younger than 6 months that are 
not exclusively breastfed (predominant, 
partial, and none). Discontinued 
breastfeeding is the proportion of 
children 6 to 23 months who receive no 
breast milk. 
Prevalence of predominant, partial, and no 
breastfeeding among children younger than 
6 months, prevalence of children 6-23 
months who receive no breastmilk. 
Suboptimal breastfeeding is either non-
exclusive breastfeeding for infants under 6 
months or discontinued breastfeeding for 
children 6-23 months.  
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Protection Vitamin A deficiency Serum retinol less than 70 μmol/L Prevalence of Vitamin A deficiency. 
The prevalence of Vitamin A deficiency 
among children younger than 5 is a risk 
factor for diarrhea mortality. 
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Table 2. The number of deaths due to diarrhea among children younger than 5 years in 2017, the mortality rate per 100,000, the 
percent change in mortality rate between 1990-2017, the absolute difference in mortality rates between 1990-2017, and the attributable 
fraction for nutrition, vaccine, unsafe WASH, low ORS, and all risk factors by GBD super-region, region, and country. 
Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
Global 
533,768 
(477,162-
593,145) 
78.4 
(70.1-87.1) 
-69.6% 
(-74.6 to -
63.1%) 
-179.5 
(-149.2 to -
207.1) 
88.5% 
(81.3 to 92.4%) 
22.0% 
(16.7 to 27.9%) 
94.0% 
(85.9 to 98.1%) 
57.7% 
(39.9 to 70.8%) 
99.4% 
(98.7 to 99.8%) 
 Southeast 
Asia, East 
Asia, and 
Oceania 
22,105 
(19,881-24,679) 
15.6 
(14.0-17.4) 
-83.1% 
(-85.5 to -79.9%) 
-76.7 
(-65.6 to -88.6) 
88.1% 
(79.8 to 92.1%) 
29.5% 
(20.7 to 39.8%) 
85.7% 
(66.4 to 95.6%) 
54.8% 
(37.1 to 68.1%) 
98.6% 
(96.8 to 99.6%) 
  East Asia 
2,645 
(2,309-3,198) 
3.1 
(2.7-3.8) 
-95.1% 
(-95.9 to -94.1%) 
-60.5 
(-52.3 to -70.9) 
77.3% 
(61.4 to 86.2%) 
9.9% 
(4.5 to 19.7%) 
77.4% 
(58.2 to 91.2%) 
55.5% 
(37.8 to 68.7%) 
95.1% 
(89.8 to 98.2%) 
   China 
2,343 
(2,046-2,699) 
2.9 
(2.5-3.4) 
-95.5% 
(-96.4 to -94.6%) 
-62.1 
(-53.7 to -72.6) 
76.5% 
(60.4 to 85.5%) 
7.8% 
(3.2 to 16.7%) 
78.3% 
(59.0 to 91.8%) 
55.5% 
(37.8 to 68.8%) 
95.0% 
(89.6 to 98.2%) 
   North 
Korea 
254 
(137-887) 
18.9 
(10.2-66.1) 
-36.9% 
(-66.7 to 15.2%) 
-11.0 
(-5.4 to -0.8) 
86.2% 
(74.2 to 92.7%) 
25.6% 
(16.2 to 36.4%) 
70.1% 
(51.4 to 86.0%) 
56.0% 
(37.6 to 70.7%) 
96.3% 
(92.8 to 98.5%) 
   Taiwan 
6 
(4-8) 
0.6 
(0.4-0.8) 
-66.9% 
(-77.5 to -53.4%) 
-1.2 
(-1.0 to -1.4) 
69.4% 
(52.2 to 80.3%) 
22.1% 
(13.9 to 31.6%) 
37.0% 
(18.0 to 61.9%) 
55.1% 
(36.3 to 68.9%) 
83.5% 
(73.8 to 91.0%) 
  Southeast 
Asia 
18,009 
(15,924-20,389) 
32.4 
(28.6-36.7) 
-79.3% 
(-83.3 to -73.7%) 
-123.9 
(-96.8 to -
152.3) 
89.5% 
(82.3 to 93.0%) 
33.3% 
(23.8 to 44.5%) 
86.2% 
(66.0 to 95.9%) 
54.1% 
(36.4 to 67.5%) 
99.0% 
(97.4 to 99.7%) 
   Cambodia 
300 
(195-451) 
16.8 
(10.9-25.2) 
-92.9% 
(-95.9 to -87.7%) 
-220.7 
(-160.4 to -
299.0) 
85.4% 
(75.3 to 91.8%) 
36.9% 
(31.8 to 41.6%) 
89.7% 
(74.6 to 97.1%) 
58.1% 
(40.0 to 71.8%) 
99.0% 
(97.4 to 99.8%) 
   Indonesia 
10,568 
(9,121-12,150) 
50.3 
(43.4-57.9) 
-79.2% 
(-83.9 to -71.9%) 
-191.3 
(-139.5 to -
252.7) 
90.8% 
(85.1 to 93.7%) 
38.3% 
(24.6 to 53.6%) 
84.6% 
(61.4 to 95.6%) 
55.4% 
(37.8 to 68.6%) 
99.2% 
(97.7 to 99.8%) 
   Laos 
949 
(510-1,513) 
117.9 
(63.3-187.9) 
-78.9% 
(-87.8 to -65.4%) 
-441.8 
(-247.4 to -
648.2) 
86.3% 
(75.3 to 92.3%) 
41.8% 
(35.6 to 47.9%) 
93.4% 
(83.2 to 98.2%) 
54.6% 
(35.8 to 68.9%) 
99.3% 
(98.1 to 99.8%) 
   Malaysia 
54 
(32-82) 
2.1 
(1.2-3.1) 
-80.0% 
(-88.9 to -64.5%) 
-8.3 
(-6.0 to -11.6) 
85.7% 
(75.0 to 92.0%) 
16.8% 
(10.8 to 24.4%) 
55.4% 
(24.5 to 80.9%) 
55.5% 
(36.7 to 69.9%) 
95.8% 
(91.6 to 98.4%) 
   Maldives 
1 
(0-1) 
1.6 
(1.0-2.5) 
-95.8% 
(-97.9 to -91.1%) 
-37.0 
(-19.8 to -66.1) 
85.5% 
(73.4 to 92.2%) 
30.6% 
(20.0 to 43.6%) 
87.8% 
(70.6 to 96.4%) 
49.9% 
(31.2 to 65.5%) 
98.7% 
(96.7 to 99.7%) 
   Mauritius 
4 
(3-5) 
6.0 
(4.4-7.8) 
-80.4% 
(-85.9 to -72.2%) 
-24.6 
(-21.0 to -28.5) 
85.2% 
(74.1 to 90.9%) 
10.5% 
(5.0 to 18.9%) 
28.1% 
(13.8 to 48.1%) 
55.7% 
(37.0 to 69.8%) 
93.0% 
(87.0 to 96.0%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Myanmar 
2,003 
(1,330-2,921) 
45.4 
(30.2-66.3) 
-83.7% 
(-90.7 to -71.2%) 
-232.7 
(-140.6 to -
354.5) 
86.3% 
(74.0 to 92.6%) 
38.1% 
(32.9 to 43.2%) 
93.0% 
(81.7 to 98.1%) 
49.2% 
(31.2 to 64.1%) 
99.2% 
(98.0 to 99.8%) 
   Philippines 
3,763 
(2,638-5,239) 
31.5 
(22.1-43.9) 
-64.8% 
(-76.8 to -49.4%) 
-57.9 
(-53.5 to -60.9) 
89.0% 
(78.4 to 94.1%) 
16.6% 
(10.3 to 25.0%) 
85.5% 
(64.6 to 95.6%) 
53.0% 
(34.8 to 67.3%) 
98.5% 
(96.2 to 99.6%) 
   Sri Lanka 
12 
(7-19) 
0.7 
(0.5-1.2) 
-96.6% 
(-98.2 to -94.1%) 
-21.2 
(-14.6 to -29.3) 
85.6% 
(75.0 to 92.0%) 
19.3% 
(12.4 to 28.0%) 
84.5% 
(64.0 to 95.1%) 
59.2% 
(41.3 to 72.5%) 
98.6% 
(96.5 to 99.6%) 
   Seychelles 
0 
(0-0) 
2.7 
(1.8-3.9) 
-22.5% 
(-55.0 to 29.2%) 
-0.8 
(-0.5 to -1.4) 
81.8% 
(66.7 to 89.8%) 
7.6% 
(3.1 to 15.2%) 
78.2% 
(52.1 to 93.0%) 
55.8% 
(36.1 to 70.5%) 
96.8% 
(92.3 to 99.1%) 
   Thailand 
129 
(87-179) 
3.8 
(2.6-5.3) 
-84.6% 
(-90.4 to -75.0%) 
-21.1 
(-14.2 to -30.9) 
84.3% 
(70.1 to 91.5%) 
43.5% 
(35.6 to 51.8%) 
83.7% 
(59.8 to 95.2%) 
48.3% 
(30.6 to 63.7%) 
98.0% 
(94.7 to 99.5%) 
   Timor-Leste 
75 
(35-129) 
42.9 
(20.2-74.0) 
-87.7% 
(-93.6 to -77.9%) 
-305.2 
(-154.4 to -
522.4) 
93.5% 
(87.3 to 96.6%) 
30.3% 
(19.6 to 43.5%) 
92.7% 
(81.9 to 98.0%) 
42.2% 
(24.6 to 58.4%) 
99.7% 
(99.0 to 99.9%) 
   Vietnam 
128 
(81-197) 
1.6 
(1.0-2.6) 
-95.6% 
(-97.8 to -89.1%) 
-36.3 
(-17.0 to -60.4) 
83.7% 
(71.5 to 91.0%) 
37.5% 
(30.2 to 46.2%) 
86.3% 
(66.3 to 95.9%) 
56.1% 
(38.8 to 70.2%) 
98.4% 
(95.7 to 99.6%) 
  Oceania 
1,450 
(961-2,127) 
81.5 
(54.0-119.6) 
-37.3% 
(-60.7 to 0.0%) 
-48.5 
(-41.3 to -52.2) 
88.1% 
(80.5 to 93.0%) 
21.5% 
(13.9 to 31.0%) 
94.8% 
(86.7 to 98.6%) 
61.7% 
(44.0 to 74.5%) 
99.5% 
(98.8 to 99.9%) 
   American 
Samoa 
0 
(0-0) 
2.3 
(1.4-3.7) 
-54.2% 
(-76.2 to -15.5%) 
-2.8 
(-2.0 to -3.7) 
78.2% 
(59.8 to 87.8%) 
26.1% 
(17.0 to 37.6%) 
69.1% 
(39.3 to 88.5%) 
61.0% 
(43.6 to 73.8%) 
94.1% 
(87.4 to 98.1%) 
   Federated 
States of 
Micronesia 
0 
(0-1) 
3.5 
(1.8-6.0) 
-91.0% 
(-95.7 to -84.3%) 
-35.8 
(-25.0 to -49.1) 
83.7% 
(68.7 to 92.3%) 
18.8% 
(11.5 to 28.6%) 
83.1% 
(62.6 to 94.6%) 
60.0% 
(42.2 to 72.8%) 
97.6% 
(94.1 to 99.3%) 
   Fiji 
22 
(14-33) 
23.4 
(14.8-35.5) 
-17.0% 
(-54.3 to 49.8%) 
-4.8 
(-4.0 to -5.2) 
82.6% 
(66.1 to 90.7%) 
8.4% 
(3.9 to 15.7%) 
76.5% 
(51.9 to 91.8%) 
59.1% 
(40.7 to 72.5%) 
96.5% 
(92.0 to 98.9%) 
   Guam 
0 
(0-0) 
0.9 
(0.6-1.3) 
-33.5% 
(-60.1 to 6.8%) 
-0.4 
(-0.3 to -0.6) 
76.2% 
(57.9 to 86.6%) 
26.6% 
(17.6 to 37.8%) 
59.8% 
(27.1 to 83.7%) 
59.7% 
(41.7 to 73.2%) 
91.7% 
(83.0 to 97.0%) 
   Kiribati 
7 
(4-11) 
44.1 
(27.2-65.1) 
-81.7% 
(-89.5 to -69.5%) 
-196.3 
(-145.2 to -
257.6) 
88.7% 
(78.2 to 94.1%) 
14.5% 
(8.2 to 23.0%) 
92.1% 
(80.4 to 97.8%) 
59.0% 
(39.6 to 72.7%) 
99.3% 
(98.1 to 99.8%) 
   Marshall 
Islands 
0 
(0-1) 
5.2 
(3.2-8.1) 
-74.6% 
(-85.3 to -56.4%) 
-15.3 
(-9.9 to -22.1) 
83.6% 
(68.7 to 91.3%) 
18.9% 
(11.5 to 28.5%) 
85.4% 
(65.8 to 95.4%) 
61.9% 
(44.1 to 74.9%) 
97.9% 
(94.9 to 99.4%) 
   Northern 
Mariana 
Islands 
0 
(0-0) 
0.6 
(0.4-0.9) 
-35.5% 
(-62.2 to 13.6%) 
-0.4 
(-0.2 to -0.6) 
74.6% 
(55.8 to 85.5%) 
25.5% 
(17.0 to 36.9%) 
62.9% 
(31.7 to 85.0%) 
59.5% 
(41.0 to 72.8%) 
92.1% 
(83.6 to 97.3%) 
   Papua New 
Guinea 
1,312 
(848-1,955) 
96.8 
(62.6-144.2) 
-42.4% 
(-65.2 to -4.9%) 
-71.3 
(-56.0 to -84.8) 
88.3% 
(80.9 to 93.2%) 
21.7% 
(13.9 to 31.3%) 
95.2% 
(87.4 to 98.8%) 
61.8% 
(44.0 to 74.7%) 
99.6% 
(98.9 to 99.9%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Samoa 
1 
(0-1) 
2.1 
(1.1-3.6) 
-65.7% 
(-80.9 to -37.7%) 
-4.1 
(-2.3 to -6.7) 
75.2% 
(55.4 to 86.5%) 
26.1% 
(17.0 to 37.6%) 
61.1% 
(31.6 to 83.6%) 
59.3% 
(40.9 to 72.4%) 
91.3% 
(82.5 to 96.8%) 
   Solomon 
Islands 
17 
(10-27) 
18.4 
(10.7-29.0) 
-72.4% 
(-84.3 to -52.5%) 
-48.2 
(-28.7 to -71.8) 
82.6% 
(67.2 to 91.1%) 
25.5% 
(16.6 to 37.4%) 
91.8% 
(80.6 to 97.5%) 
60.0% 
(41.8 to 73.2%) 
98.7% 
(96.7 to 99.6%) 
   Tonga 
0 
(0-0) 
2.4 
(1.6-3.5) 
-75.6% 
(-85.6 to -59.2%) 
-7.6 
(-5.1 to -10.7) 
81.7% 
(65.9 to 89.7%) 
25.0% 
(16.6 to 36.3%) 
78.1% 
(51.4 to 92.5%) 
58.9% 
(40.7 to 72.2%) 
96.5% 
(91.5 to 99.0%) 
   Vanuatu 
9 
(5-14) 
22.3 
(12.6-35.7) 
-58.1% 
(-76.8 to -25.4%) 
-30.9 
(-18.5 to -46.7) 
84.5% 
(71.4 to 91.9%) 
25.7% 
(16.8 to 36.9%) 
94.2% 
(85.4 to 98.4%) 
61.5% 
(43.7 to 74.3%) 
99.2% 
(97.9 to 99.8%) 
 Central 
Europe, 
Eastern 
Europe, and 
Central Asia 
2,395 
(1,907-3,032) 
8.6 
(6.8-10.8) 
-78.6% 
(-83.2 to -72.8%) 
-31.4 
(-30.5 to -31.8) 
85.3% 
(75.4 to 90.8%) 
8.0% 
(5.0 to 12.2%) 
82.5% 
(66.8 to 93.3%) 
51.1% 
(33.7 to 65.0%) 
97.7% 
(95.4 to 99.1%) 
  Central Asia 
2,187 
(1,703-2,812) 
22.8 
(17.8-29.3) 
-82.2% 
(-86.4 to -76.8%) 
-105.1 
(-100.5 to -
108.4) 
86.2% 
(76.8 to 91.5%) 
6.5% 
(4.0 to 10.3%) 
85.0% 
(69.3 to 94.8%) 
50.5% 
(33.1 to 64.6%) 
98.3% 
(96.3 to 99.4%) 
   Armenia 
6 
(4-7) 
2.7 
(2.0-3.6) 
-96.9% 
(-97.7 to -95.6%) 
-84.0 
(-71.3 to -97.9) 
71.2% 
(54.0 to 82.0%) 
2.0% 
(0.6 to 4.9%) 
53.6% 
(39.8 to 71.0%) 
52.1% 
(32.2 to 67.3%) 
88.7% 
(81.2 to 94.0%) 
   Azerbaijan 
161 
(103-242) 
19.0 
(12.1-28.5) 
-87.8% 
(-92.6 to -80.2%) 
-136.2 
(-113.5 to -
160.7) 
79.3% 
(64.4 to 88.1%) 
10.2% 
(8.1 to 12.5%) 
72.7% 
(54.0 to 88.6%) 
61.8% 
(44.5 to 74.9%) 
95.6% 
(91.5 to 98.3%) 
   Georgia 
7 
(5-9) 
2.7 
(1.9-3.6) 
-90.6% 
(-93.7 to -86.6%) 
-25.7 
(-20.8 to -32.5) 
73.7% 
(57.3 to 84.2%) 
4.8% 
(2.2 to 8.8%) 
71.3% 
(51.0 to 87.9%) 
56.2% 
(37.0 to 70.4%) 
93.6% 
(87.6 to 97.5%) 
   Kazakhstan 
64 
(43-88) 
3.4 
(2.3-4.6) 
-95.0% 
(-96.7 to -92.9%) 
-64.8 
(-55.1 to -75.5) 
75.5% 
(58.7 to 85.3%) 
15.4% 
(9.2 to 23.2%) 
72.9% 
(53.8 to 88.6%) 
48.2% 
(29.3 to 64.2%) 
94.1% 
(88.6 to 97.8%) 
   Kyrgyzstan 
118 
(92-147) 
15.2 
(11.9-19.0) 
-85.2% 
(-89.2 to -80.3%) 
-87.7 
(-75.0 to -
102.7) 
71.3% 
(53.8 to 82.4%) 
12.1% 
(7.1 to 18.3%) 
84.9% 
(70.9 to 94.6%) 
48.0% 
(29.6 to 63.5%) 
96.0% 
(91.5 to 98.6%) 
   Mongolia 
27 
(18-39) 
7.0 
(4.8-10.1) 
-81.1% 
(-89.2 to -67.6%) 
-30.0 
(-20.7 to -41.5) 
68.4% 
(51.7 to 80.8%) 
35.5% 
(30.1 to 40.5%) 
90.0% 
(76.0 to 97.1%) 
54.8% 
(36.7 to 69.0%) 
97.5% 
(93.7 to 99.3%) 
   Tajikistan 
1,590 
(1,108-2,208) 
127.5 
(88.8-177.1) 
-68.1% 
(-78.2 to -54.3%) 
-272.2 
(-245.8 to -
292.0) 
90.1% 
(83.1 to 94.4%) 
4.1% 
(1.7 to 8.1%) 
87.5% 
(71.9 to 96.1%) 
48.5% 
(31.4 to 63.3%) 
99.2% 
(98.0 to 99.8%) 
   
Turkmenistan 
58 
(40-83) 
10.6 
(7.2-15.0) 
-93.6% 
(-95.7 to -90.6%) 
-154.8 
(-133.3 to -
178.0) 
74.0% 
(56.8 to 84.0%) 
13.0% 
(7.9 to 19.3%) 
81.8% 
(62.8 to 93.5%) 
54.7% 
(36.5 to 69.0%) 
96.0% 
(91.2 to 98.7%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Uzbekistan 
156 
(110-215) 
4.5 
(3.2-6.3) 
-95.7% 
(-97.0 to -93.8%) 
-100.1 
(-86.2 to -
114.2) 
78.3% 
(63.8 to 86.9%) 
1.5% 
(0.4 to 4.0%) 
80.2% 
(63.0 to 92.4%) 
59.2% 
(41.2 to 72.5%) 
96.7% 
(93.1 to 98.8%) 
  Central 
Europe 
70 
(61-82) 
1.2 
(1.1-1.4) 
-83.4% 
(-86.4 to -79.4%) 
-6.2 
(-5.6 to -7.0) 
79.1% 
(65.2 to 86.6%) 
28.6% 
(18.8 to 40.0%) 
47.0% 
(26.6 to 68.9%) 
58.7% 
(40.9 to 71.9%) 
90.4% 
(84.0 to 95.0%) 
   Albania 
2 
(1-4) 
1.3 
(0.7-2.3) 
-91.8% 
(-95.8 to -84.8%) 
-14.6 
(-11.4 to -18.6) 
86.3% 
(74.3 to 93.1%) 
18.8% 
(11.4 to 27.4%) 
69.8% 
(44.3 to 88.2%) 
56.8% 
(38.6 to 71.5%) 
97.0% 
(94.0 to 99.0%) 
   Bosnia and 
Herzegovina 
2 
(1-3) 
1.3 
(0.9-1.9) 
-75.2% 
(-85.7 to -56.1%) 
-4.0 
(-2.6 to -5.7) 
78.5% 
(63.0 to 89.0%) 
25.0% 
(15.6 to 35.7%) 
47.6% 
(24.0 to 72.3%) 
59.1% 
(40.3 to 73.1%) 
91.4% 
(85.7 to 95.9%) 
   Bulgaria 
8 
(6-12) 
2.6 
(1.8-3.7) 
-44.7% 
(-65.1 to -14.9%) 
-2.1 
(-2.0 to -2.2) 
79.9% 
(64.0 to 88.6%) 
26.0% 
(16.6 to 37.3%) 
38.1% 
(14.0 to 66.5%) 
58.7% 
(40.3 to 73.2%) 
88.8% 
(80.5 to 94.7%) 
   Croatia 
2 
(1-2) 
0.9 
(0.7-1.2) 
-43.4% 
(-62.5 to -11.7%) 
-0.7 
(-0.6 to -0.9) 
77.1% 
(60.1 to 86.7%) 
25.7% 
(16.0 to 36.9%) 
34.3% 
(13.9 to 60.4%) 
58.3% 
(39.2 to 73.2%) 
86.5% 
(77.3 to 92.7%) 
   Czech 
Republic 
3 
(2-5) 
0.6 
(0.4-0.9) 
54.7% 
(-6.4 to 140.0%) 
0.2 
(0.1 to 0.3) 
78.8% 
(62.7 to 87.9%) 
25.9% 
(16.2 to 37.3%) 
23.3% 
(8.2 to 47.6%) 
58.6% 
(39.3 to 72.7%) 
85.9% 
(76.7 to 91.5%) 
   Hungary 
4 
(3-5) 
0.8 
(0.6-1.1) 
145.1% 
(59.6 to 252.9%) 
0.5 
(0.3 to 0.7) 
76.2% 
(59.2 to 86.2%) 
14.6% 
(9.1 to 21.3%) 
33.5% 
(17.4 to 56.9%) 
58.5% 
(40.5 to 73.3%) 
86.5% 
(78.0 to 92.2%) 
   Macedonia 
3 
(2-5) 
2.7 
(1.8-4.1) 
-97.2% 
(-98.3 to -95.5%) 
-95.1 
(-71.3 to -
120.3) 
78.1% 
(61.1 to 87.8%) 
25.9% 
(16.2 to 37.7%) 
44.4% 
(22.8 to 69.0%) 
53.1% 
(33.3 to 68.6%) 
89.3% 
(81.5 to 94.7%) 
   Montenegro 
0 
(0-0) 
0.4 
(0.3-0.7) 
-78.9% 
(-89.6 to -58.7%) 
-1.7 
(-1.1 to -2.5) 
79.8% 
(63.6 to 89.3%) 
26.1% 
(16.3 to 37.5%) 
56.1% 
(28.7 to 80.4%) 
61.2% 
(42.9 to 74.6%) 
92.7% 
(86.5 to 97.1%) 
   Poland 
6 
(5-8) 
0.3 
(0.3-0.4) 
-88.2% 
(-92.1 to -82.8%) 
-2.5 
(-2.0 to -3.0) 
72.6% 
(57.2 to 82.8%) 
37.5% 
(23.9 to 53.7%) 
31.8% 
(13.1 to 57.0%) 
59.0% 
(39.6 to 73.4%) 
85.6% 
(77.1 to 91.9%) 
   Romania 
32 
(24-42) 
3.4 
(2.5-4.4) 
-78.7% 
(-84.9 to -69.9%) 
-12.4 
(-10.6 to -14.5) 
80.6% 
(65.7 to 88.6%) 
31.4% 
(21.1 to 44.6%) 
59.1% 
(37.8 to 79.5%) 
59.0% 
(39.5 to 73.6%) 
93.3% 
(87.6 to 97.0%) 
   Serbia 
3 
(2-5) 
0.7 
(0.5-1.0) 
-67.2% 
(-80.9 to -44.2%) 
-1.4 
(-1.0 to -2.0) 
80.2% 
(64.9 to 89.1%) 
25.8% 
(16.4 to 37.1%) 
41.2% 
(16.6 to 67.6%) 
62.0% 
(44.3 to 75.0%) 
90.8% 
(83.6 to 95.4%) 
   Slovakia 
4 
(3-6) 
1.4 
(0.9-2.1) 
0.2% 
(-38.8 to 74.2%) 
0.0 
(-0.1 to 0.2) 
75.3% 
(57.3 to 85.9%) 
25.6% 
(15.9 to 37.0%) 
26.6% 
(10.3 to 51.1%) 
58.6% 
(39.0 to 73.3%) 
84.4% 
(74.9 to 91.0%) 
   Slovenia 
0 
(0-0) 
0.2 
(0.2-0.3) 
-64.7% 
(-77.4 to -48.1%) 
-0.5 
(-0.4 to -0.5) 
73.0% 
(55.5 to 83.7%) 
25.5% 
(16.2 to 36.6%) 
24.5% 
(10.5 to 46.0%) 
58.6% 
(39.1 to 73.2%) 
83.0% 
(73.7 to 89.5%) 
  Eastern 
Europe 
138 
(122-154) 
1.1 
(1.0-1.2) 
-87.3% 
(-88.8 to -85.8%) 
-7.4 
(-7.0 to -7.9) 
74.5% 
(60.7 to 81.8%) 
31.4% 
(20.2 to 44.5%) 
62.2% 
(43.7 to 79.4%) 
56.3% 
(38.4 to 69.7%) 
92.2% 
(86.3 to 96.2%) 
   Belarus 
1 
(1-2) 
0.3 
(0.2-0.4) 
-95.2% 
(-96.9 to -92.7%) 
-5.2 
(-4.3 to -6.3) 
71.2% 
(54.4 to 81.8%) 
23.9% 
(15.1 to 34.2%) 
53.5% 
(34.4 to 74.5%) 
55.9% 
(36.7 to 70.7%) 
88.4% 
(80.2 to 94.2%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Estonia 
0 
(0-0) 
0.4 
(0.2-0.5) 
-87.8% 
(-92.4 to -81.3%) 
-2.6 
(-2.1 to -3.3) 
70.3% 
(51.7 to 81.9%) 
2.8% 
(1.1 to 5.7%) 
41.3% 
(21.3 to 65.3%) 
56.8% 
(37.4 to 72.3%) 
85.1% 
(75.6 to 92.3%) 
   Latvia 
1 
(0-1) 
0.6 
(0.4-0.9) 
-75.6% 
(-86.4 to -60.0%) 
-1.9 
(-1.6 to -2.3) 
71.3% 
(52.5 to 82.2%) 
6.6% 
(2.8 to 12.5%) 
49.8% 
(28.3 to 73.1%) 
56.6% 
(37.1 to 72.5%) 
87.0% 
(77.8 to 93.7%) 
   Lithuania 
1 
(1-1) 
0.7 
(0.5-1.0) 
-71.9% 
(-82.0 to -58.1%) 
-1.8 
(-1.5 to -2.2) 
72.0% 
(53.0 to 82.6%) 
23.5% 
(14.7 to 34.0%) 
50.0% 
(28.4 to 73.4%) 
57.0% 
(37.0 to 71.8%) 
87.4% 
(78.6 to 93.9%) 
   Moldova 
5 
(3-7) 
2.6 
(1.8-3.7) 
-88.2% 
(-92.1 to -83.1%) 
-19.7 
(-16.6 to -23.4) 
71.5% 
(56.6 to 81.9%) 
14.2% 
(8.1 to 22.1%) 
85.5% 
(70.8 to 94.9%) 
57.9% 
(39.8 to 72.4%) 
96.7% 
(92.9 to 98.9%) 
   Russian 
Federation 
113 
(102-126) 
1.2 
(1.1-1.3) 
-87.2% 
(-88.6 to -85.9%) 
-8.3 
(-7.7 to -8.8) 
74.3% 
(60.7 to 81.6%) 
33.6% 
(21.6 to 47.7%) 
59.9% 
(41.1 to 78.1%) 
57.2% 
(39.3 to 70.3%) 
91.7% 
(85.5 to 96.0%) 
   Ukraine 
16 
(11-22) 
0.7 
(0.5-0.9) 
-87.4% 
(-91.3 to -82.6%) 
-4.8 
(-4.1 to -5.6) 
77.9% 
(61.7 to 86.9%) 
25.8% 
(16.2 to 37.2%) 
73.8% 
(53.9 to 89.1%) 
49.5% 
(29.0 to 67.6%) 
95.2% 
(90.3 to 98.2%) 
 High-income 
706 
(618-769) 
1.2 
(1.1-1.3) 
-44.0% 
(-52.9 to -35.7%) 
-1.0 
(-0.9 to -1.1) 
69.3% 
(53.4 to 79.0%) 
10.6% 
(6.0 to 16.5%) 
19.6% 
(11.6 to 30.0%) 
57.1% 
(39.6 to 70.2%) 
77.0% 
(67.2 to 83.6%) 
  High-
income Asia 
Pacific 
53 
(45-61) 
0.7 
(0.6-0.8) 
-43.5% 
(-56.0 to -28.5%) 
-0.5 
(-0.5 to -0.7) 
72.0% 
(55.8 to 81.0%) 
16.1% 
(10.3 to 23.2%) 
21.7% 
(10.3 to 40.3%) 
56.6% 
(38.5 to 69.8%) 
81.1% 
(70.4 to 87.9%) 
   Brunei 
0 
(0-0) 
1.0 
(0.7-1.5) 
-8.3% 
(-44.8 to 45.8%) 
-0.1 
(-0.1 to -0.1) 
71.4% 
(54.7 to 82.0%) 
19.5% 
(12.2 to 28.5%) 
22.8% 
(10.3 to 42.3%) 
56.9% 
(38.3 to 71.2%) 
82.0% 
(72.2 to 88.8%) 
   Japan 
42 
(36-48) 
0.8 
(0.7-1.0) 
8.0% 
(-11.3 to 29.8%) 
0.1 
(0.0 to 0.1) 
73.7% 
(57.4 to 82.3%) 
16.0% 
(10.1 to 23.3%) 
21.8% 
(10.2 to 41.4%) 
56.6% 
(38.6 to 69.7%) 
82.1% 
(71.4 to 88.8%) 
   South Korea 
10 
(8-14) 
0.5 
(0.4-0.6) 
-79.5% 
(-86.3 to -69.6%) 
-1.8 
(-1.4 to -2.3) 
65.9% 
(46.4 to 78.4%) 
15.9% 
(10.3 to 22.7%) 
21.2% 
(10.0 to 39.9%) 
56.7% 
(37.7 to 71.0%) 
76.8% 
(65.6 to 84.6%) 
   Singapore 
0 
(0-0) 
0.1 
(0.1-0.1) 
49.6% 
(-4.7 to 123.8%) 
0.0 
(0.0 to 0.0) 
74.6% 
(61.2 to 83.8%) 
26.7% 
(17.3 to 38.0%) 
21.0% 
(9.9 to 39.2%) 
56.7% 
(38.5 to 70.9%) 
85.2% 
(76.8 to 90.8%) 
  Australasia 
12 
(8-17) 
0.7 
(0.5-0.9) 
61.1% 
(-4.1 to 143.1%) 
0.3 
(0.1 to 0.4) 
66.8% 
(47.3 to 78.6%) 
4.1% 
(1.8 to 8.2%) 
22.3% 
(10.3 to 40.8%) 
56.9% 
(39.0 to 70.1%) 
75.6% 
(63.8 to 83.8%) 
   Australia 
10 
(6-14) 
0.7 
(0.4-0.9) 
76.9% 
(-0.2 to 179.4%) 
0.3 
(0.1 to 0.5) 
67.2% 
(47.5 to 79.4%) 
3.3% 
(1.2 to 7.7%) 
20.9% 
(9.4 to 39.3%) 
56.9% 
(38.9 to 70.5%) 
75.5% 
(63.7 to 83.8%) 
   New 
Zealand 
2 
(2-3) 
0.8 
(0.6-1.0) 
22.4% 
(-26.3 to 78.6%) 
0.1 
(0.0 to 0.2) 
64.9% 
(45.1 to 77.5%) 
7.3% 
(3.2 to 13.7%) 
27.9% 
(13.1 to 49.3%) 
56.9% 
(39.0 to 70.6%) 
75.8% 
(63.4 to 85.0%) 
  Western 
Europe 
129 
(114-146) 
0.6 
(0.5-0.7) 
-25.0% 
(-44.2 to -6.8%) 
-0.2 
(-0.2 to -0.3) 
69.1% 
(52.5 to 79.1%) 
18.5% 
(11.9 to 26.8%) 
8.9% 
(5.1 to 15.0%) 
56.7% 
(39.0 to 70.0%) 
74.9% 
(63.5 to 81.6%) 
   Andorra 
0 
(0-0) 
0.3 
(0.2-0.5) 
-16.6% 
(-53.0 to 52.0%) 
-0.1 
(0.0 to -0.1) 
68.7% 
(45.9 to 82.8%) 
27.5% 
(16.5 to 40.1%) 
6.6% 
(3.5 to 11.3%) 
56.7% 
(38.1 to 70.6%) 
73.0% 
(60.4 to 81.1%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Austria 
2 
(2-3) 
0.5 
(0.4-0.7) 
334.4% 
(169.9 to 
585.4%) 
0.4 
(0.3 to 0.5) 
69.3% 
(49.4 to 82.1%) 
6.0% 
(2.2 to 12.5%) 
11.3% 
(7.2 to 16.9%) 
56.7% 
(38.2 to 71.0%) 
76.4% 
(64.9 to 83.5%) 
   Belgium 
5 
(4-7) 
0.8 
(0.6-1.1) 
32.6% 
(-21.5 to 
107.5%) 
0.2 
(0.1 to 0.2) 
69.5% 
(49.1 to 82.6%) 
4.3% 
(1.7 to 9.1%) 
7.4% 
(4.1 to 12.4%) 
56.7% 
(38.8 to 70.4%) 
73.6% 
(60.4 to 81.5%) 
   Cyprus 
0 
(0-0) 
0.3 
(0.2-0.5) 
-61.2% 
(-79.9 to -18.5%) 
-0.5 
(-0.2 to -0.8) 
70.5% 
(51.8 to 83.8%) 
26.7% 
(16.3 to 38.5%) 
9.6% 
(4.8 to 17.6%) 
56.8% 
(38.0 to 70.6%) 
79.7% 
(70.2 to 86.1%) 
   Denmark 
3 
(2-4) 
0.9 
(0.7-1.3) 
17.2% 
(-27.4 to 79.8%) 
0.1 
(0.1 to 0.2) 
68.7% 
(51.5 to 80.7%) 
46.4% 
(30.1 to 64.4%) 
6.5% 
(3.5 to 11.4%) 
56.7% 
(38.1 to 71.2%) 
74.9% 
(64.2 to 81.8%) 
   Finland 
1 
(0-1) 
0.2 
(0.1-0.3) 
-69.9% 
(-81.7 to -51.8%) 
-0.4 
(-0.3 to -0.5) 
68.7% 
(50.3 to 81.2%) 
10.6% 
(4.5 to 20.6%) 
6.7% 
(3.7 to 11.3%) 
56.6% 
(37.9 to 70.8%) 
75.7% 
(64.3 to 82.2%) 
   France 
28 
(20-37) 
0.7 
(0.5-1.0) 
-61.0% 
(-74.2 to -42.4%) 
-1.1 
(-1.0 to -1.5) 
64.8% 
(44.8 to 77.2%) 
37.7% 
(25.2 to 52.9%) 
9.8% 
(5.1 to 17.8%) 
56.9% 
(37.9 to 70.9%) 
70.7% 
(56.7 to 79.2%) 
   Germany 
19 
(14-26) 
0.5 
(0.4-0.7) 
-3.9% 
(-37.3 to 42.4%) 
0.0 
(0.0 to 0.0) 
64.3% 
(45.2 to 77.0%) 
20.5% 
(12.1 to 31.2%) 
7.8% 
(4.4 to 13.4%) 
56.7% 
(38.8 to 70.7%) 
71.1% 
(59.7 to 79.0%) 
   Greece 
1 
(1-2) 
0.2 
(0.1-0.3) 
30.2% 
(-23.7 to 
125.9%) 
0.1 
(0.0 to 0.0) 
74.0% 
(56.6 to 85.8%) 
13.3% 
(7.6 to 20.0%) 
8.7% 
(5.2 to 13.4%) 
56.8% 
(38.0 to 71.5%) 
80.1% 
(70.6 to 86.1%) 
   Iceland 
0 
(0-0) 
0.6 
(0.4-0.9) 
49.3% 
(-7.1 to 139.0%) 
0.2 
(0.1 to 0.3) 
69.2% 
(48.9 to 82.2%) 
21.2% 
(13.5 to 30.6%) 
6.4% 
(3.4 to 11.2%) 
56.7% 
(38.1 to 70.9%) 
73.9% 
(61.5 to 81.5%) 
   Ireland 
2 
(1-2) 
0.5 
(0.4-0.7) 
102.6% 
(23.4 to 213.1%) 
0.3 
(0.2 to 0.4) 
71.2% 
(52.5 to 83.4%) 
15.6% 
(9.6 to 22.6%) 
9.2% 
(5.7 to 14.6%) 
56.6% 
(37.8 to 70.8%) 
76.7% 
(66.1 to 83.5%) 
   Israel 
9 
(6-11) 
1.0 
(0.7-1.3) 
-14.7% 
(-41.8 to 22.1%) 
-0.2 
(-0.1 to -0.3) 
71.4% 
(53.2 to 82.3%) 
7.7% 
(3.2 to 15.6%) 
10.0% 
(5.8 to 16.8%) 
56.7% 
(37.9 to 70.4%) 
77.2% 
(65.9 to 83.8%) 
   Italy 
13 
(9-18) 
0.5 
(0.4-0.7) 
50.0% 
(1.3 to 120.5%) 
0.2 
(0.1 to 0.3) 
77.6% 
(61.9 to 86.8%) 
18.5% 
(12.3 to 26.1%) 
10.9% 
(6.2 to 18.9%) 
56.7% 
(38.5 to 70.8%) 
81.9% 
(72.7 to 87.2%) 
   
Luxembourg 
0 
(0-0) 
0.9 
(0.6-1.2) 
-37.8% 
(-67.4 to 2.7%) 
-0.5 
(-0.5 to -0.7) 
69.1% 
(49.8 to 82.0%) 
3.4% 
(1.3 to 7.5%) 
6.6% 
(3.6 to 11.7%) 
56.6% 
(38.3 to 70.7%) 
74.3% 
(62.5 to 81.9%) 
   Malta 
0 
(0-0) 
0.4 
(0.2-0.6) 
46.0% 
(-11.2 to 
140.3%) 
0.1 
(0.1 to 0.2) 
71.0% 
(52.7 to 83.2%) 
26.9% 
(16.3 to 38.8%) 
9.0% 
(5.1 to 14.8%) 
56.8% 
(37.5 to 70.9%) 
77.2% 
(66.7 to 84.0%) 
   
Netherlands 
4 
(3-5) 
0.4 
(0.3-0.6) 
123.1% 
(41.0 to 242.7%) 
0.2 
(0.2 to 0.4) 
71.1% 
(51.2 to 83.4%) 
37.2% 
(23.6 to 53.4%) 
6.3% 
(3.5 to 10.8%) 
56.7% 
(38.2 to 70.4%) 
75.4% 
(63.4 to 82.9%) 
   Norway 
1 
(1-1) 
0.3 
(0.3-0.4) 
45.0% 
(4.4 to 87.2%) 
0.1 
(0.1 to 0.1) 
68.3% 
(51.3 to 79.2%) 
24.5% 
(15.4 to 35.3%) 
6.4% 
(3.4 to 10.7%) 
56.6% 
(39.1 to 69.6%) 
73.8% 
(62.1 to 81.3%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Portugal 
4 
(3-6) 
1.0 
(0.7-1.4) 
-71.7% 
(-82.0 to -56.6%) 
-2.5 
(-1.9 to -3.5) 
74.0% 
(56.7 to 85.1%) 
13.2% 
(8.5 to 19.1%) 
22.1% 
(13.1 to 35.8%) 
56.8% 
(38.2 to 70.9%) 
82.7% 
(73.7 to 88.1%) 
   Spain 
11 
(8-15) 
0.5 
(0.4-0.7) 
-32.1% 
(-55.6 to 2.4%) 
-0.3 
(-0.2 to -0.3) 
70.3% 
(52.8 to 81.0%) 
25.1% 
(17.2 to 34.8%) 
8.0% 
(3.8 to 15.2%) 
56.8% 
(38.7 to 70.7%) 
76.7% 
(65.5 to 83.2%) 
   Sweden 
3 
(2-3) 
0.4 
(0.3-0.6) 
280.4% 
(149.3 to 
439.0%) 
0.3 
(0.2 to 0.4) 
67.6% 
(48.0 to 79.9%) 
31.9% 
(19.9 to 46.3%) 
7.4% 
(4.0 to 12.5%) 
56.6% 
(37.8 to 70.5%) 
72.5% 
(60.1 to 80.2%) 
   Switzerland 
4 
(3-6) 
1.0 
(0.7-1.4) 
-41.4% 
(-62.5 to -12.2%) 
-0.7 
(-0.6 to -1.1) 
70.6% 
(56.7 to 81.3%) 
27.8% 
(18.0 to 39.7%) 
6.9% 
(4.0 to 11.7%) 
56.6% 
(38.3 to 70.8%) 
80.1% 
(72.2 to 85.0%) 
   United 
Kingdom 
19 
(17-21) 
0.5 
(0.4-0.5) 
115.1% 
(65.7 to 159.6%) 
0.3 
(0.2 to 0.3) 
70.1% 
(53.1 to 80.6%) 
1.2% 
(0.4 to 2.8%) 
6.3% 
(2.9 to 12.0%) 
56.8% 
(38.9 to 69.9%) 
74.5% 
(62.4 to 82.1%) 
   England 
16 
(14-17) 
0.5 
(0.4-0.5) 
100.1% 
(54.1 to 140.1%) 
0.2 
(0.2 to 0.2) 
69.3% 
(52.2 to 79.7%) 
0.7% 
(0.2 to 1.6%) 
6.1% 
(2.8 to 11.7%) 
56.8% 
(39.2 to 69.8%) 
73.8% 
(61.5 to 81.4%) 
   Northern 
Ireland 
1 
(1-1) 
0.6 
(0.4-1.0) 
189.4% 
(67.2 to 360.3%) 
0.4 
(0.2 to 0.7) 
73.1% 
(54.1 to 85.4%) 
2.6% 
(0.6 to 7.8%) 
6.6% 
(3.0 to 13.1%) 
56.9% 
(39.1 to 70.4%) 
77.4% 
(66.2 to 84.9%) 
   Scotland 
2 
(1-3) 
0.6 
(0.4-1.0) 
214.1% 
(69.0 to 461.0%) 
0.4 
(0.2 to 0.7) 
73.9% 
(54.7 to 86.1%) 
3.1% 
(0.7 to 9.0%) 
7.4% 
(3.3 to 14.9%) 
56.9% 
(38.3 to 70.4%) 
77.9% 
(66.5 to 84.9%) 
   Wales 
1 
(1-1) 
0.6 
(0.4-0.8) 
246.7% 
(111.8 to 
477.9%) 
0.4 
(0.3 to 0.6) 
74.3% 
(55.6 to 86.4%) 
3.5% 
(0.8 to 11.0%) 
7.4% 
(3.3 to 15.1%) 
56.9% 
(38.3 to 70.7%) 
78.2% 
(66.8 to 85.4%) 
  Southern 
Latin 
America 
141 
(114-170) 
2.8 
(2.2-3.3) 
-83.4% 
(-87.1 to -79.0%) 
-13.9 
(-12.6 to -15.3) 
76.4% 
(61.2 to 85.2%) 
10.1% 
(5.2 to 16.7%) 
49.6% 
(26.5 to 74.4%) 
57.8% 
(40.2 to 71.6%) 
89.6% 
(82.3 to 95.2%) 
   Argentina 
124 
(97-154) 
3.4 
(2.6-4.2) 
-83.6% 
(-87.8 to -78.4%) 
-17.2 
(-15.2 to -19.5) 
77.3% 
(62.2 to 86.1%) 
8.5% 
(4.1 to 14.8%) 
51.0% 
(27.3 to 76.2%) 
57.9% 
(40.0 to 71.8%) 
90.4% 
(83.0 to 95.7%) 
   Chile 
9 
(6-13) 
0.8 
(0.5-1.1) 
-89.4% 
(-93.0 to -84.4%) 
-6.5 
(-5.6 to -7.5) 
67.5% 
(50.5 to 79.0%) 
26.5% 
(17.2 to 37.8%) 
39.8% 
(23.5 to 60.9%) 
57.6% 
(39.1 to 71.6%) 
82.7% 
(73.6 to 89.9%) 
   Uruguay 
8 
(6-11) 
3.3 
(2.4-4.5) 
-79.7% 
(-85.8 to -71.2%) 
-13.1 
(-11.0 to -15.2) 
72.3% 
(55.6 to 82.7%) 
23.9% 
(15.3 to 34.6%) 
40.1% 
(18.1 to 67.0%) 
57.1% 
(38.1 to 71.3%) 
86.2% 
(77.3 to 92.9%) 
  High-
income North 
America 
371 
(314-410) 
1.7 
(1.5-1.9) 
125.3% 
(76.4 to 164.1%) 
1.0 
(0.8 to 1.0) 
66.9% 
(50.4 to 77.7%) 
7.9% 
(3.8 to 13.6%) 
11.6% 
(7.1 to 17.9%) 
56.9% 
(39.1 to 70.2%) 
72.4% 
(61.5 to 79.8%) 
   Canada 
17 
(12-24) 
0.9 
(0.6-1.2) 
616.2% 
(355.5 to 
993.9%) 
0.7 
(0.5 to 1.0) 
72.1% 
(55.7 to 82.4%) 
9.3% 
(5.3 to 14.3%) 
9.6% 
(5.7 to 15.2%) 
56.7% 
(37.5 to 70.3%) 
78.2% 
(68.7 to 84.2%) 
   Greenland 
0 
(0-0) 
5.1 
(3.3-8.0) 
40.1% 
(-30.3 to 
189.4%) 
1.5 
(1.2 to 1.9) 
70.0% 
(50.5 to 81.6%) 
16.5% 
(9.7 to 24.1%) 
19.8% 
(12.7 to 30.0%) 
57.3% 
(38.0 to 71.1%) 
77.2% 
(66.2 to 84.3%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   United 
States 
353 
(298-392) 
1.8 
(1.5-2.0) 
118.8% 
(69.5 to 157.8%) 
1.0 
(0.8 to 1.0) 
66.6% 
(50.1 to 77.5%) 
7.7% 
(3.7 to 13.6%) 
11.7% 
(7.2 to 18.1%) 
57.0% 
(39.1 to 70.2%) 
72.1% 
(61.2 to 79.7%) 
 Latin 
America and 
Caribbean 
9,904 
(8,527-11,490) 
19.5 
(16.7-22.6) 
-90.0% 
(-91.5 to -88.1%) 
-175.6 
(-165.7 to -
185.4) 
79.4% 
(65.6 to 87.3%) 
8.0% 
(4.9 to 12.1%) 
82.0% 
(67.5 to 92.1%) 
55.7% 
(37.6 to 69.1%) 
96.2% 
(92.6 to 98.5%) 
  Caribbean 
3,513 
(2,358-5,044) 
89.8 
(60.3-128.9) 
-72.4% 
(-82.1 to -57.9%) 
-236.1 
(-212.3 to -
262.3) 
83.9% 
(70.9 to 91.2%) 
6.9% 
(4.4 to 10.0%) 
95.8% 
(88.9 to 98.9%) 
53.7% 
(35.3 to 67.7%) 
99.5% 
(98.6 to 99.9%) 
   Antigua 
and Barbuda 
0 
(0-0) 
4.7 
(3.1-7.1) 
-50.5% 
(-70.4 to -16.6%) 
-4.8 
(-4.1 to -5.3) 
71.0% 
(52.0 to 82.0%) 
18.3% 
(11.5 to 26.8%) 
83.9% 
(61.9 to 95.0%) 
56.3% 
(38.7 to 70.7%) 
95.9% 
(89.8 to 98.8%) 
   The 
Bahamas 
1 
(1-1) 
3.5 
(2.3-5.3) 
-69.5% 
(-81.7 to -48.7%) 
-8.1 
(-5.9 to -10.4) 
72.3% 
(53.1 to 82.9%) 
11.3% 
(6.1 to 18.3%) 
79.3% 
(54.9 to 93.2%) 
56.7% 
(37.9 to 70.8%) 
94.9% 
(87.7 to 98.4%) 
   Barbados 
0 
(0-1) 
2.3 
(1.4-3.5) 
-68.8% 
(-82.7 to -48.1%) 
-5.0 
(-4.1 to -6.2) 
73.4% 
(55.7 to 83.3%) 
19.3% 
(12.1 to 28.2%) 
75.4% 
(51.6 to 91.1%) 
47.6% 
(29.3 to 63.4%) 
94.5% 
(88.1 to 98.2%) 
   Belize 
5 
(4-8) 
14.4 
(9.5-21.2) 
-77.2% 
(-86.0 to -63.8%) 
-48.7 
(-39.5 to -58.5) 
77.7% 
(62.8 to 85.8%) 
15.7% 
(9.5 to 23.3%) 
91.5% 
(78.9 to 97.5%) 
53.7% 
(35.2 to 68.2%) 
98.4% 
(95.8 to 99.6%) 
   Bermuda 
0 
(0-0) 
0.8 
(0.5-1.1) 
-80.7% 
(-88.4 to -68.5%) 
-3.3 
(-2.4 to -4.3) 
69.1% 
(48.8 to 81.6%) 
18.2% 
(11.2 to 26.8%) 
77.3% 
(51.5 to 92.3%) 
56.5% 
(38.0 to 70.3%) 
93.6% 
(85.1 to 98.0%) 
   Cuba 
9 
(7-13) 
1.6 
(1.1-2.1) 
-85.0% 
(-90.0 to -78.4%) 
-8.9 
(-7.3 to -11.0) 
73.9% 
(56.0 to 83.6%) 
24.4% 
(15.5 to 35.0%) 
84.5% 
(64.2 to 95.2%) 
51.1% 
(32.0 to 65.6%) 
96.4% 
(91.3 to 99.0%) 
   Dominica 
0 
(0-1) 
11.0 
(6.7-16.9) 
-19.2% 
(-51.7 to 36.6%) 
-2.6 
(-3.4 to -0.9) 
74.1% 
(56.3 to 84.1%) 
19.3% 
(11.9 to 28.1%) 
86.2% 
(68.2 to 95.7%) 
56.4% 
(37.4 to 70.2%) 
96.9% 
(92.2 to 99.2%) 
   Dominican 
Republic 
183 
(116-279) 
18.3 
(11.7-28.0) 
-92.7% 
(-95.6 to -88.2%) 
-231.0 
(-184.5 to -
280.9) 
78.7% 
(61.9 to 88.0%) 
9.7% 
(5.2 to 16.4%) 
91.6% 
(78.7 to 97.7%) 
54.9% 
(35.5 to 69.2%) 
98.4% 
(95.9 to 99.6%) 
   Grenada 
0 
(0-0) 
2.5 
(1.5-4.0) 
-83.2% 
(-91.3 to -69.0%) 
-12.2 
(-8.9 to -16.1) 
74.5% 
(56.2 to 84.9%) 
19.1% 
(11.9 to 28.0%) 
86.3% 
(68.4 to 95.6%) 
56.4% 
(37.1 to 70.2%) 
97.0% 
(92.7 to 99.1%) 
   Guyana 
17 
(11-25) 
23.5 
(15.6-34.0) 
-82.4% 
(-89.1 to -72.7%) 
-110.2 
(-91.0 to -
130.4) 
84.3% 
(72.0 to 90.7%) 
5.7% 
(2.1 to 12.7%) 
91.8% 
(79.1 to 97.7%) 
55.4% 
(36.8 to 69.5%) 
99.0% 
(97.3 to 99.8%) 
   Haiti 
3,138 
(2,033-4,608) 
211.7 
(137.1-310.9) 
-77.6% 
(-86.2 to -63.7%) 
-731.3 
(-611.0 to -
870.0) 
84.4% 
(71.7 to 91.5%) 
6.5% 
(4.2 to 9.3%) 
96.3% 
(90.0 to 99.1%) 
53.6% 
(34.8 to 67.8%) 
99.6% 
(98.9 to 99.9%) 
   Jamaica 
7 
(4-12) 
3.9 
(2.4-6.2) 
-93.8% 
(-96.4 to -89.7%) 
-59.2 
(-48.1 to -71.9) 
71.1% 
(52.2 to 82.6%) 
18.9% 
(11.9 to 27.7%) 
89.4% 
(75.3 to 96.8%) 
53.9% 
(35.0 to 68.4%) 
97.5% 
(94.0 to 99.3%) 
   Puerto Rico 
4 
(3-5) 
2.4 
(1.7-3.2) 
83.2% 
(22.8 to 181.7%) 
1.1 
(0.7 to 1.5) 
73.5% 
(56.8 to 83.3%) 
4.5% 
(1.5 to 11.0%) 
75.3% 
(46.4 to 91.7%) 
56.4% 
(37.8 to 71.8%) 
94.4% 
(87.0 to 98.3%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Saint Lucia 
0 
(0-1) 
4.4 
(2.7-6.7) 
-79.8% 
(-87.9 to -67.4%) 
-17.4 
(-13.7 to -21.3) 
75.2% 
(57.4 to 85.1%) 
19.1% 
(12.0 to 27.9%) 
84.6% 
(64.9 to 95.1%) 
66.4% 
(49.3 to 78.1%) 
96.9% 
(92.3 to 99.1%) 
   Saint 
Vincent and 
the 
Grenadines 
1 
(0-1) 
9.6 
(6.1-14.1) 
-77.6% 
(-86.3 to -64.5%) 
-33.3 
(-27.0 to -41.6) 
75.9% 
(59.6 to 85.7%) 
19.4% 
(12.0 to 28.3%) 
88.9% 
(73.5 to 96.7%) 
56.5% 
(37.8 to 70.6%) 
97.8% 
(94.6 to 99.4%) 
   Suriname 
13 
(10-18) 
28.1 
(21.0-36.8) 
-82.5% 
(-87.6 to -76.0%) 
-132.3 
(-110.3 to -
154.1) 
80.4% 
(65.2 to 88.4%) 
15.9% 
(9.8 to 23.2%) 
86.6% 
(68.5 to 95.9%) 
55.9% 
(38.3 to 70.1%) 
97.9% 
(94.6 to 99.4%) 
   Trinidad 
and Tobago 
6 
(4-9) 
6.4 
(4.1-9.8) 
-55.8% 
(-73.5 to -28.3%) 
-8.1 
(-7.5 to -8.2) 
76.7% 
(59.4 to 86.5%) 
19.2% 
(12.2 to 28.2%) 
82.2% 
(60.7 to 94.1%) 
56.7% 
(38.0 to 71.2%) 
96.6% 
(91.4 to 99.0%) 
   Virgin 
Islands, U.S. 
0 
(0-0) 
1.3 
(0.8-2.0) 
-74.3% 
(-85.3 to -55.7%) 
-3.9 
(-2.9 to -5.0) 
70.4% 
(52.0 to 81.7%) 
9.0% 
(3.9 to 16.2%) 
78.2% 
(51.4 to 93.0%) 
56.7% 
(37.8 to 70.6%) 
94.5% 
(87.1 to 98.4%) 
  Andean 
Latin 
America 
754 
(560-1,003) 
11.2 
(8.4-15.0) 
-94.5% 
(-96.0 to -92.4%) 
-193.7 
(-163.8 to -
227.1) 
70.4% 
(53.3 to 81.4%) 
5.1% 
(2.7 to 8.7%) 
77.0% 
(54.8 to 91.3%) 
60.3% 
(42.0 to 73.0%) 
93.5% 
(86.7 to 97.7%) 
   Bolivia 
238 
(123-397) 
16.4 
(8.5-27.3) 
-95.4% 
(-97.7 to -92.1%) 
-344.7 
(-257.6 to -
453.3) 
70.6% 
(51.9 to 82.7%) 
6.8% 
(2.7 to 13.3%) 
75.0% 
(50.1 to 90.8%) 
59.3% 
(41.5 to 72.4%) 
93.0% 
(85.3 to 97.6%) 
   Ecuador 
149 
(100-210) 
9.6 
(6.4-13.5) 
-93.6% 
(-95.9 to -90.7%) 
-141.4 
(-125.4 to -
159.6) 
74.8% 
(57.4 to 85.6%) 
6.0% 
(2.6 to 11.2%) 
71.5% 
(45.2 to 88.8%) 
59.5% 
(40.2 to 72.8%) 
93.2% 
(86.0 to 97.7%) 
   Peru 
366 
(236-558) 
9.9 
(6.4-15.1) 
-94.3% 
(-96.5 to -90.8%) 
-165.0 
(-123.3 to -
208.2) 
68.3% 
(50.7 to 80.0%) 
1.8% 
(0.9 to 3.2%) 
80.5% 
(60.4 to 93.0%) 
61.3% 
(43.5 to 73.9%) 
94.0% 
(87.6 to 97.9%) 
  Central 
Latin 
America 
3,781 
(3,269-4,428) 
15.6 
(13.5-18.3) 
-89.9% 
(-91.4 to -88.0%) 
-138.4 
(-132.7 to -
143.5) 
76.3% 
(62.5 to 84.9%) 
10.5% 
(6.3 to 16.3%) 
74.4% 
(55.8 to 88.3%) 
58.7% 
(41.1 to 71.5%) 
94.6% 
(89.7 to 97.8%) 
   Colombia 
298 
(203-437) 
7.0 
(4.8-10.3) 
-90.2% 
(-93.3 to -85.7%) 
-64.7 
(-56.5 to -73.5) 
69.7% 
(51.6 to 81.1%) 
6.7% 
(2.7 to 14.1%) 
70.5% 
(44.4 to 88.7%) 
53.2% 
(35.8 to 66.9%) 
91.6% 
(83.0 to 96.9%) 
   Costa Rica 
10 
(7-14) 
2.8 
(2.0-4.0) 
-83.5% 
(-88.7 to -76.1%) 
-14.3 
(-11.6 to -18.1) 
70.0% 
(50.2 to 81.7%) 
25.0% 
(16.2 to 36.4%) 
49.3% 
(26.5 to 73.6%) 
59.3% 
(41.3 to 72.1%) 
85.5% 
(75.1 to 92.9%) 
   El Salvador 
61 
(34-102) 
11.2 
(6.2-18.7) 
-95.6% 
(-97.7 to -92.3%) 
-244.3 
(-200.1 to -
291.6) 
77.0% 
(59.2 to 86.7%) 
5.8% 
(2.1 to 13.0%) 
83.6% 
(66.8 to 94.3%) 
53.0% 
(35.3 to 66.8%) 
96.5% 
(92.2 to 98.9%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Guatemala 
1,288 
(890-1,797) 
64.8 
(44.8-90.4) 
-85.5% 
(-90.2 to -79.6%) 
-381.1 
(-347.2 to -
413.0) 
72.2% 
(58.9 to 82.0%) 
17.3% 
(10.3 to 26.5%) 
89.5% 
(75.3 to 96.7%) 
56.4% 
(38.1 to 69.5%) 
97.2% 
(93.2 to 99.2%) 
   Honduras 
271 
(132-484) 
23.1 
(11.3-41.2) 
-91.9% 
(-95.9 to -85.6%) 
-263.6 
(-224.9 to -
305.0) 
74.1% 
(57.7 to 84.6%) 
4.9% 
(1.7 to 11.0%) 
82.1% 
(65.0 to 93.7%) 
50.5% 
(33.0 to 64.5%) 
95.9% 
(91.3 to 98.7%) 
   Mexico 
1,247 
(1,123-1,406) 
10.3 
(9.3-11.7) 
-92.4% 
(-93.3 to -91.2%) 
-125.4 
(-116.9 to -
133.7) 
79.7% 
(65.6 to 87.6%) 
6.7% 
(3.1 to 12.2%) 
59.7% 
(40.3 to 78.1%) 
65.9% 
(48.7 to 77.5%) 
92.0% 
(86.1 to 96.1%) 
   Nicaragua 
86 
(57-125) 
12.7 
(8.4-18.3) 
-96.7% 
(-97.9 to -95.0%) 
-374.7 
(-321.0 to -
429.5) 
71.3% 
(53.8 to 82.3%) 
0.1% 
(0.0 to 0.4%) 
86.9% 
(72.0 to 95.8%) 
50.8% 
(33.3 to 64.7%) 
96.5% 
(92.1 to 98.9%) 
   Panama 
77 
(52-110) 
21.4 
(14.3-30.4) 
-48.3% 
(-65.6 to -24.0%) 
-20.0 
(-17.4 to -23.5) 
69.6% 
(51.2 to 81.0%) 
8.0% 
(3.5 to 15.8%) 
75.8% 
(55.1 to 90.9%) 
52.4% 
(34.0 to 66.0%) 
92.9% 
(85.6 to 97.5%) 
   Venezuela 
443 
(321-597) 
15.7 
(11.4-21.2) 
-85.6% 
(-90.0 to -79.9%) 
-93.8 
(-82.6 to -
104.5) 
84.8% 
(70.4 to 91.2%) 
14.9% 
(8.0 to 25.0%) 
66.8% 
(40.3 to 86.5%) 
57.0% 
(38.9 to 70.2%) 
95.4% 
(90.0 to 98.4%) 
  Tropical 
Latin 
America 
1,856 
(1,647-2,087) 
11.5 
(10.2-13.0) 
-94.6% 
(-95.4 to -93.6%) 
-202.7 
(-178.9 to -
225.0) 
79.8% 
(64.7 to 88.2%) 
2.2% 
(0.8 to 4.9%) 
73.6% 
(56.7 to 87.7%) 
51.7% 
(33.6 to 66.5%) 
94.5% 
(89.9 to 97.6%) 
   Brazil 
1,795 
(1,586-2,025) 
11.7 
(10.3-13.2) 
-94.6% 
(-95.4 to -93.6%) 
-206.7 
(-181.8 to -
229.6) 
79.8% 
(64.7 to 88.2%) 
2.2% 
(0.8 to 5.0%) 
73.5% 
(56.6 to 87.6%) 
51.3% 
(33.0 to 66.4%) 
94.5% 
(89.9 to 97.6%) 
   Paraguay 
61 
(36-101) 
8.2 
(4.8-13.5) 
-91.3% 
(-95.0 to -85.2%) 
-85.7 
(-70.8 to -
100.9) 
78.9% 
(61.6 to 88.2%) 
1.1% 
(0.4 to 3.0%) 
76.0% 
(54.8 to 91.3%) 
64.2% 
(43.0 to 77.5%) 
95.1% 
(89.9 to 98.4%) 
 North Africa 
and Middle 
East 
28,962 
(23,106-35,611) 
45.0 
(35.9-55.3) 
-80.7% 
(-84.8 to -75.3%) 
-188.5 
(-149.5 to -
227.8) 
88.0% 
(78.6 to 92.8%) 
17.2% 
(11.0 to 25.1%) 
87.0% 
(74.9 to 94.9%) 
61.2% 
(43.6 to 73.6%) 
98.3% 
(96.5 to 99.4%) 
   Afghanistan 
5,911 
(3,994-8,431) 
100.4 
(67.8-143.2) 
-81.1% 
(-89.8 to -62.3%) 
-430.1 
(-211.1 to -
674.5) 
87.4% 
(77.5 to 93.1%) 
27.1% 
(17.1 to 39.4%) 
96.1% 
(89.7 to 99.0%) 
61.1% 
(43.2 to 73.7%) 
99.6% 
(99.0 to 99.9%) 
   Algeria 
166 
(79-280) 
3.7 
(1.8-6.3) 
-90.1% 
(-94.7 to -82.0%) 
-33.7 
(-19.9 to -52.3) 
82.9% 
(69.2 to 90.6%) 
26.5% 
(16.6 to 38.1%) 
63.1% 
(39.3 to 83.6%) 
59.3% 
(41.7 to 72.1%) 
94.7% 
(89.7 to 97.9%) 
   Bahrain 
1 
(1-1) 
0.8 
(0.5-1.1) 
-73.7% 
(-85.0 to -55.5%) 
-2.1 
(-1.3 to -3.2) 
77.8% 
(59.1 to 87.2%) 
1.3% 
(0.3 to 4.1%) 
63.2% 
(38.7 to 83.6%) 
59.0% 
(41.3 to 72.0%) 
92.3% 
(84.4 to 97.0%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Egypt 
6,457 
(3,827-9,531) 
54.7 
(32.4-80.8) 
-89.1% 
(-93.4 to -82.8%) 
-445.1 
(-378.8 to -
514.7) 
79.2% 
(63.4 to 88.1%) 
23.8% 
(16.6 to 32.4%) 
66.4% 
(48.0 to 83.7%) 
58.5% 
(41.0 to 71.4%) 
94.7% 
(90.0 to 97.7%) 
   Iran 
191 
(168-212) 
2.8 
(2.5-3.1) 
-94.6% 
(-96.0 to -92.5%) 
-49.2 
(-36.1 to -62.9) 
78.8% 
(63.8 to 86.1%) 
48.8% 
(31.9 to 67.7%) 
67.8% 
(43.6 to 86.3%) 
59.1% 
(41.3 to 71.8%) 
94.4% 
(88.9 to 97.8%) 
   Iraq 
561 
(401-780) 
9.5 
(6.8-13.1) 
-84.9% 
(-90.6 to -75.2%) 
-53.3 
(-37.0 to -72.7) 
86.8% 
(75.2 to 92.7%) 
16.2% 
(9.1 to 25.5%) 
75.9% 
(54.4 to 91.0%) 
58.4% 
(40.3 to 71.4%) 
97.7% 
(94.9 to 99.2%) 
   Jordan 
35 
(23-52) 
3.0 
(1.9-4.5) 
-87.3% 
(-92.8 to -76.3%) 
-20.4 
(-12.4 to -30.0) 
77.4% 
(60.9 to 87.2%) 
3.5% 
(1.3 to 7.8%) 
56.8% 
(32.8 to 78.8%) 
62.1% 
(44.7 to 74.5%) 
91.6% 
(84.7 to 96.3%) 
   Kuwait 
3 
(2-4) 
1.1 
(0.7-1.5) 
-76.9% 
(-84.7 to -64.3%) 
-3.5 
(-2.7 to -4.4) 
73.4% 
(55.7 to 84.0%) 
26.8% 
(17.1 to 38.7%) 
52.8% 
(28.5 to 76.7%) 
60.7% 
(43.1 to 73.4%) 
89.6% 
(81.4 to 95.3%) 
   Lebanon 
32 
(11-64) 
3.6 
(1.3-7.1) 
-82.7% 
(-92.1 to -66.6%) 
-17.2 
(-7.5 to -29.3) 
78.3% 
(59.7 to 88.1%) 
26.9% 
(16.9 to 38.9%) 
73.0% 
(45.5 to 90.4%) 
56.6% 
(38.9 to 69.9%) 
95.0% 
(88.9 to 98.4%) 
   Libya 
21 
(12-34) 
3.3 
(1.8-5.3) 
-90.2% 
(-94.6 to -82.1%) 
-30.7 
(-15.5 to -50.6) 
79.8% 
(61.4 to 89.3%) 
6.5% 
(2.5 to 13.2%) 
71.5% 
(49.0 to 88.1%) 
59.1% 
(41.1 to 71.9%) 
95.0% 
(89.6 to 98.2%) 
   Morocco 
687 
(372-1,144) 
22.4 
(12.1-37.3) 
-92.2% 
(-96.0 to -86.5%) 
-266.7 
(-214.8 to -
321.0) 
81.2% 
(65.9 to 89.8%) 
4.1% 
(1.3 to 10.5%) 
79.6% 
(57.7 to 93.3%) 
60.4% 
(42.7 to 72.9%) 
96.7% 
(92.5 to 99.0%) 
   Palestine 
17 
(12-25) 
2.6 
(1.8-3.8) 
-75.7% 
(-86.4 to -55.0%) 
-8.2 
(-4.7 to -12.5) 
78.3% 
(61.6 to 87.8%) 
7.5% 
(2.9 to 15.1%) 
81.7% 
(59.0 to 94.3%) 
59.9% 
(42.2 to 72.7%) 
96.7% 
(92.3 to 99.1%) 
   Oman 
4 
(2-6) 
1.0 
(0.6-1.5) 
-95.4% 
(-97.8 to -88.5%) 
-19.7 
(-10.7 to -30.7) 
82.7% 
(70.0 to 90.1%) 
46.2% 
(30.2 to 65.1%) 
65.1% 
(37.9 to 85.5%) 
59.1% 
(41.3 to 72.1%) 
96.3% 
(92.1 to 98.6%) 
   Qatar 
1 
(1-2) 
0.7 
(0.5-1.1) 
-66.3% 
(-80.6 to -40.0%) 
-1.4 
(-0.9 to -2.2) 
77.2% 
(58.6 to 87.1%) 
4.0% 
(1.4 to 9.3%) 
55.9% 
(31.1 to 79.8%) 
59.0% 
(41.3 to 71.8%) 
90.9% 
(83.0 to 96.4%) 
   Saudi 
Arabia 
36 
(20-64) 
1.5 
(0.8-2.6) 
-98.1% 
(-99.1 to -95.9%) 
-75.6 
(-46.3 to -
119.5) 
73.5% 
(53.0 to 84.7%) 
3.7% 
(1.3 to 8.7%) 
54.6% 
(29.5 to 78.2%) 
59.2% 
(41.4 to 72.1%) 
88.8% 
(79.7 to 95.3%) 
   Sudan 
7,215 
(3,821-11,469) 
118.9 
(63.0-189.1) 
-76.2% 
(-86.2 to -58.2%) 
-380.7 
(-220.5 to -
548.6) 
90.6% 
(82.4 to 95.2%) 
7.2% 
(4.0 to 11.6%) 
95.7% 
(89.2 to 98.9%) 
62.8% 
(45.1 to 75.1%) 
99.7% 
(99.3 to 99.9%) 
   Syria 
18 
(10-27) 
1.2 
(0.7-1.9) 
-97.0% 
(-98.5 to -94.5%) 
-39.8 
(-26.1 to -55.3) 
85.9% 
(73.4 to 92.8%) 
26.9% 
(17.3 to 38.6%) 
66.2% 
(42.3 to 85.9%) 
64.1% 
(46.6 to 76.1%) 
96.7% 
(93.0 to 98.8%) 
   Tunisia 
21 
(9-40) 
2.3 
(1.0-4.4) 
-92.6% 
(-96.5 to -85.5%) 
-28.7 
(-13.5 to -47.7) 
73.1% 
(53.6 to 85.2%) 
19.0% 
(14.0 to 24.9%) 
74.7% 
(52.3 to 90.4%) 
48.7% 
(31.2 to 62.5%) 
94.2% 
(88.3 to 98.0%) 
   Turkey 
151 
(100-220) 
2.6 
(1.7-3.7) 
-98.0% 
(-98.8 to -96.5%) 
-124.9 
(-86.4 to -
177.7) 
74.0% 
(55.6 to 85.1%) 
16.9% 
(13.1 to 21.4%) 
73.5% 
(48.8 to 90.1%) 
63.7% 
(46.2 to 75.8%) 
93.3% 
(86.4 to 97.7%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   United 
Arab 
Emirates 
6 
(4-9) 
1.5 
(0.9-2.3) 
-70.6% 
(-84.5 to -40.0%) 
-3.5 
(-2.1 to -5.6) 
79.9% 
(65.2 to 89.0%) 
5.7% 
(2.2 to 12.0%) 
55.8% 
(29.1 to 79.5%) 
59.0% 
(41.1 to 72.0%) 
95.0% 
(90.2 to 98.1%) 
   Yemen 
7,400 
(4,726-11,260) 
154.0 
(98.4-234.4) 
-80.4% 
(-87.6 to -66.7%) 
-630.1 
(-334.1 to -
887.5) 
94.3% 
(89.3 to 97.0%) 
16.7% 
(9.6 to 26.3%) 
92.7% 
(82.3 to 98.0%) 
62.5% 
(45.0 to 74.7%) 
99.8% 
(99.4 to 99.9%) 
 South Asia 
135,390 
(115,688-
156,734) 
77.6 
(66.3-89.9) 
-81.4% 
(-85.8 to -76.1%) 
-339.4 
(-282.5 to -
397.7) 
89.6% 
(84.1 to 92.9%) 
16.9% 
(10.9 to 24.5%) 
92.9% 
(82.9 to 97.9%) 
53.5% 
(36.1 to 67.7%) 
99.6% 
(99.1 to 99.9%) 
   Bangladesh 
3,062 
(1,743-5,087) 
21.0 
(11.9-34.9) 
-95.1% 
(-97.4 to -91.4%) 
-407.1 
(-329.1 to -
479.9) 
85.8% 
(74.8 to 92.4%) 
32.4% 
(27.8 to 37.0%) 
96.0% 
(89.9 to 98.9%) 
34.6% 
(19.7 to 49.2%) 
99.7% 
(99.2 to 99.9%) 
   Bhutan 
7 
(3-15) 
8.4 
(3.5-17.0) 
-95.9% 
(-98.1 to -91.7%) 
-193.9 
(-97.1 to -
339.1) 
77.9% 
(62.5 to 87.8%) 
18.9% 
(12.1 to 27.4%) 
83.1% 
(66.9 to 94.2%) 
45.7% 
(24.8 to 65.1%) 
97.1% 
(93.8 to 99.1%) 
   India 
102,678 
(87,608-
118,510) 
79.4 
(67.7-91.6) 
-79.7% 
(-84.4 to -73.3%) 
-311.4 
(-249.2 to -
370.1) 
89.9% 
(84.9 to 93.1%) 
19.7% 
(12.4 to 28.4%) 
92.8% 
(82.5 to 97.8%) 
53.3% 
(35.9 to 68.1%) 
99.7% 
(99.2 to 99.9%) 
   Nepal 
753 
(445-1,191) 
24.6 
(14.5-38.9) 
-94.9% 
(-97.3 to -89.6%) 
-455.6 
(-311.6 to -
633.6) 
76.9% 
(60.6 to 87.0%) 
9.8% 
(7.3 to 13.0%) 
93.5% 
(83.8 to 98.1%) 
50.6% 
(32.2 to 67.1%) 
99.0% 
(97.3 to 99.7%) 
   Pakistan 
28,890 
(18,641-43,911) 
105.7 
(68.2-160.7) 
-81.4% 
(-89.2 to -68.5%) 
-462.7 
(-355.5 to -
578.4) 
89.4% 
(81.0 to 94.3%) 
5.8% 
(4.2 to 7.7%) 
93.2% 
(83.0 to 98.1%) 
56.1% 
(35.9 to 70.3%) 
99.6% 
(98.8 to 99.9%) 
 Sub-Saharan 
Africa 
334,306 
(285,351-
388,790) 
204.6 
(174.7-238.0) 
-68.4% 
(-74.2 to -60.3%) 
-443.0 
(-352.9 to -
523.8) 
88.5% 
(80.6 to 92.6%) 
24.4% 
(19.2 to 30.0%) 
96.2% 
(90.1 to 99.0%) 
59.5% 
(41.7 to 72.4%) 
99.7% 
(99.1 to 99.9%) 
  Central Sub-
Saharan 
Africa 
34,800 
(25,798-46,206) 
176.1 
(130.6-233.9) 
-63.5% 
(-73.9 to -49.3%) 
-306.9 
(-246.9 to -
364.9) 
88.6% 
(79.2 to 93.4%) 
39.8% 
(32.0 to 47.2%) 
96.5% 
(91.2 to 99.1%) 
60.5% 
(42.2 to 73.4%) 
99.7% 
(99.2 to 99.9%) 
   Angola 
10,236 
(7,080-14,044) 
206.3 
(142.7-283.0) 
-81.2% 
(-87.8 to -70.6%) 
-891.4 
(-616.5 to -
1,176.0) 
86.8% 
(76.5 to 92.4%) 
21.7% 
(15.5 to 29.5%) 
96.0% 
(89.6 to 99.0%) 
58.1% 
(39.8 to 72.1%) 
99.6% 
(98.8 to 99.9%) 
   Central 
African 
Republic 
4,156 
(2,338-6,558) 
685.8 
(385.7-1,082.0) 
54.3% 
(-12.7 to 
167.5%) 
241.4 
(114.6 to 430.5) 
89.3% 
(81.0 to 94.1%) 
31.1% 
(24.7 to 37.6%) 
97.2% 
(92.5 to 99.3%) 
65.2% 
(47.7 to 77.1%) 
99.8% 
(99.4 to 99.9%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Congo 
710 
(410-1,098) 
112.5 
(64.9-174.0) 
-49.9% 
(-71.3 to -17.8%) 
-111.9 
(-81.8 to -
157.8) 
89.9% 
(80.2 to 94.6%) 
23.3% 
(17.0 to 30.1%) 
95.6% 
(89.2 to 98.8%) 
60.6% 
(42.2 to 73.8%) 
99.7% 
(99.1 to 99.9%) 
   Democratic 
Republic of 
the Congo 
19,514 
(12,250-29,439) 
148.2 
(93.0-223.5) 
-56.5% 
(-73.6 to -29.1%) 
-192.6 
(-153.7 to -
221.3) 
89.4% 
(80.0 to 94.7%) 
53.4% 
(46.2 to 60.2%) 
96.7% 
(91.6 to 99.1%) 
60.8% 
(42.2 to 73.6%) 
99.7% 
(99.3 to 99.9%) 
   Equatorial 
Guinea 
89 
(41-159) 
47.0 
(21.9-83.8) 
-92.2% 
(-96.5 to -84.5%) 
-555.9 
(-343.7 to -
793.6) 
81.8% 
(67.6 to 90.0%) 
42.4% 
(28.1 to 60.1%) 
92.3% 
(81.6 to 97.8%) 
59.9% 
(41.2 to 73.0%) 
98.8% 
(97.1 to 99.7%) 
   Gabon 
95 
(43-173) 
47.5 
(21.8-86.8) 
-71.6% 
(-85.0 to -49.9%) 
-119.5 
(-76.4 to -
156.6) 
79.1% 
(62.9 to 88.7%) 
40.4% 
(26.9 to 56.8%) 
91.3% 
(81.3 to 97.3%) 
59.5% 
(41.9 to 72.7%) 
98.5% 
(96.6 to 99.6%) 
  Eastern Sub-
Saharan 
Africa 
98,175 
(84,620-
114,013) 
155.1 
(133.7-180.1) 
-70.3% 
(-76.4 to -62.3%) 
-367.1 
(-287.5 to -
446.7) 
86.7% 
(78.5 to 91.2%) 
13.4% 
(8.7 to 19.0%) 
96.7% 
(91.2 to 99.2%) 
58.9% 
(41.1 to 71.5%) 
99.7% 
(99.1 to 99.9%) 
   Burundi 
3,045 
(1,829-4,944) 
166.3 
(99.9-270.0) 
-64.0% 
(-78.5 to -40.3%) 
-295.1 
(-232.7 to -
344.0) 
88.1% 
(79.0 to 93.5%) 
3.6% 
(1.1 to 9.0%) 
97.1% 
(92.3 to 99.3%) 
59.9% 
(41.2 to 74.0%) 
99.8% 
(99.3 to 99.9%) 
   Comoros 
69 
(42-108) 
80.5 
(49.0-126.4) 
-83.3% 
(-90.2 to -72.5%) 
-401.3 
(-306.5 to -
505.7) 
88.4% 
(78.5 to 94.0%) 
27.8% 
(17.9 to 39.1%) 
95.8% 
(89.4 to 98.9%) 
51.9% 
(32.7 to 68.1%) 
99.7% 
(99.2 to 99.9%) 
   Djibouti 
102 
(48-182) 
67.6 
(32.0-120.4) 
-82.2% 
(-90.5 to -69.5%) 
-311.8 
(-208.7 to -
419.4) 
89.7% 
(81.6 to 94.8%) 
17.2% 
(10.0 to 26.1%) 
95.8% 
(89.4 to 98.8%) 
61.1% 
(42.1 to 74.8%) 
99.8% 
(99.4 to 99.9%) 
   Eritrea 
1,585 
(945-2,508) 
193.4 
(115.3-306.1) 
-76.8% 
(-87.1 to -56.4%) 
-639.9 
(-394.2 to -
900.1) 
88.8% 
(79.7 to 94.1%) 
0.3% 
(0.1 to 0.8%) 
96.5% 
(90.9 to 99.1%) 
56.3% 
(36.4 to 71.9%) 
99.7% 
(99.3 to 99.9%) 
   Ethiopia 
31,805 
(26,081-38,114) 
191.3 
(156.9-229.2) 
-64.3% 
(-74.1 to -49.7%) 
-344.9 
(-234.5 to -
457.2) 
89.3% 
(82.1 to 93.1%) 
17.8% 
(11.0 to 25.9%) 
96.7% 
(91.8 to 99.2%) 
63.8% 
(45.8 to 76.0%) 
99.7% 
(99.3 to 99.9%) 
   Kenya 
9,552 
(7,681-11,489) 
146.7 
(118.0-176.5) 
-42.1% 
(-58.2 to -25.0%) 
-106.6 
(-80.0 to -
143.7) 
83.0% 
(74.0 to 88.4%) 
8.0% 
(4.1 to 13.6%) 
96.0% 
(89.8 to 99.0%) 
57.9% 
(40.2 to 71.0%) 
99.5% 
(98.7 to 99.9%) 
   Madagascar 
14,675 
(9,248-21,904) 
337.3 
(212.5-503.4) 
-56.3% 
(-73.2 to -33.4%) 
-434.5 
(-439.0 to -
401.5) 
87.2% 
(78.2 to 92.5%) 
6.3% 
(2.9 to 11.0%) 
97.0% 
(91.8 to 99.3%) 
64.0% 
(46.4 to 76.7%) 
99.7% 
(99.3 to 99.9%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Malawi 
2,538 
(1,664-3,688) 
92.6 
(60.7-134.6) 
-89.4% 
(-93.8 to -78.7%) 
-778.7 
(-429.6 to -
1,040.3) 
79.6% 
(66.0 to 87.9%) 
8.0% 
(3.5 to 15.0%) 
96.7% 
(91.4 to 99.1%) 
43.9% 
(26.9 to 61.1%) 
99.5% 
(98.6 to 99.9%) 
   
Mozambique 
4,393 
(2,905-6,257) 
93.4 
(61.8-133.1) 
-82.5% 
(-90.3 to -70.3%) 
-439.2 
(-294.4 to -
789.7) 
83.1% 
(69.9 to 90.9%) 
6.5% 
(3.4 to 11.0%) 
96.7% 
(91.4 to 99.2%) 
50.9% 
(32.1 to 66.9%) 
99.5% 
(98.8 to 99.9%) 
   Rwanda 
1,887 
(1,156-2,890) 
98.6 
(60.4-151.0) 
-88.4% 
(-93.9 to -79.4%) 
-749.4 
(-537.2 to -
1,000.8) 
77.5% 
(63.5 to 86.9%) 
3.0% 
(1.1 to 7.4%) 
96.1% 
(90.1 to 99.0%) 
60.5% 
(42.8 to 74.0%) 
99.3% 
(98.0 to 99.8%) 
   Somalia 
6,681 
(3,765-11,254) 
225.2 
(126.9-379.4) 
-68.6% 
(-81.5 to -38.3%) 
-492.5 
(-245.7 to -
778.9) 
91.3% 
(83.5 to 95.7%) 
27.5% 
(17.7 to 38.8%) 
96.8% 
(91.5 to 99.2%) 
55.2% 
(35.9 to 70.7%) 
99.8% 
(99.5 to 100.0%) 
   South 
Sudan 
7,912 
(4,971-11,405) 
452.8 
(284.5-652.7) 
-37.8% 
(-59.7 to 4.5%) 
-275.7 
(-100.4 to -
504.7) 
90.8% 
(83.8 to 95.0%) 
27.5% 
(17.7 to 38.7%) 
97.3% 
(92.7 to 99.4%) 
54.6% 
(35.1 to 69.6%) 
99.9% 
(99.6 to 100.0%) 
   Tanzania 
4,902 
(2,939-7,719) 
54.4 
(32.6-85.7) 
-86.5% 
(-92.3 to -76.1%) 
-349.8 
(-246.5 to -
443.8) 
80.8% 
(67.7 to 88.6%) 
3.7% 
(1.6 to 7.4%) 
96.0% 
(89.5 to 99.0%) 
55.0% 
(36.1 to 70.0%) 
99.4% 
(98.4 to 99.9%) 
   Uganda 
5,261 
(3,545-7,453) 
75.8 
(51.0-107.3) 
-76.3% 
(-85.6 to -59.6%) 
-243.3 
(-157.2 to -
346.5) 
77.7% 
(63.1 to 86.7%) 
27.4% 
(23.5 to 31.2%) 
96.2% 
(90.0 to 99.0%) 
54.6% 
(34.0 to 70.5%) 
99.3% 
(98.2 to 99.8%) 
   Zambia 
3,708 
(2,510-5,277) 
129.3 
(87.5-184.0) 
-78.4% 
(-86.9 to -62.9%) 
-468.2 
(-306.3 to -
647.3) 
84.6% 
(74.2 to 90.9%) 
0.8% 
(0.4 to 1.5%) 
95.8% 
(89.0 to 98.9%) 
45.2% 
(25.9 to 63.1%) 
99.5% 
(98.7 to 99.9%) 
  Southern 
Sub-Saharan 
Africa 
8,070 
(6,972-9,314) 
94.5 
(81.7-109.1) 
-67.9% 
(-73.3 to -61.4%) 
-200.1 
(-173.6 to -
223.6) 
81.5% 
(68.3 to 88.6%) 
7.1% 
(4.1 to 11.1%) 
89.0% 
(78.3 to 96.0%) 
53.2% 
(35.2 to 66.7%) 
98.3% 
(96.2 to 99.4%) 
   Botswana 
196 
(137-278) 
82.0 
(57.0-116.1) 
-62.1% 
(-75.1 to -42.9%) 
-134.3 
(-101.5 to -
166.3) 
85.0% 
(72.7 to 91.5%) 
16.1% 
(9.9 to 23.3%) 
90.7% 
(79.9 to 97.1%) 
51.2% 
(33.1 to 65.9%) 
98.8% 
(97.2 to 99.7%) 
   Lesotho 
474 
(293-738) 
209.5 
(129.6-326.1) 
-47.0% 
(-67.8 to -14.4%) 
-185.6 
(-166.8 to -
171.9) 
80.0% 
(67.2 to 88.3%) 
7.7% 
(3.3 to 14.7%) 
96.7% 
(91.6 to 99.2%) 
49.4% 
(31.3 to 64.3%) 
99.4% 
(98.5 to 99.9%) 
   Namibia 
321 
(194-492) 
110.8 
(67.2-170.0) 
-67.0% 
(-80.0 to -50.8%) 
-225.3 
(-170.3 to -
256.2) 
86.1% 
(73.4 to 92.2%) 
4.0% 
(1.6 to 8.0%) 
92.5% 
(82.4 to 97.7%) 
43.1% 
(25.8 to 57.5%) 
99.1% 
(97.9 to 99.8%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   South 
Africa 
4,616 
(3,941-5,353) 
84.9 
(72.5-98.5) 
-76.8% 
(-81.0 to -72.2%) 
-281.1 
(-243.2 to -
317.7) 
82.9% 
(70.2 to 89.6%) 
5.1% 
(2.2 to 9.5%) 
84.5% 
(70.9 to 94.0%) 
53.3% 
(35.7 to 67.0%) 
97.6% 
(95.0 to 99.2%) 
   Swaziland 
247 
(154-379) 
170.3 
(106.2-261.2) 
-50.3% 
(-67.7 to -27.0%) 
-172.6 
(-101.6 to -
210.4) 
75.7% 
(61.1 to 85.1%) 
11.9% 
(6.1 to 19.9%) 
94.8% 
(87.3 to 98.6%) 
41.3% 
(24.6 to 56.6%) 
98.8% 
(97.0 to 99.7%) 
   Zimbabwe 
2,216 
(1,457-3,112) 
100.6 
(66.2-141.3) 
6.4% 
(-34.7 to 76.6%) 
6.1 
(1.8 to 11.1) 
78.7% 
(64.1 to 87.7%) 
10.5% 
(6.2 to 16.1%) 
95.5% 
(88.5 to 98.8%) 
56.7% 
(38.7 to 70.2%) 
99.1% 
(97.8 to 99.8%) 
  Western 
Sub-Saharan 
Africa 
193,260 
(157,286-
236,075) 
269.3 
(219.1-328.9) 
-70.1% 
(-76.9 to -60.2%) 
-630.4 
(-480.1 to -
785.7) 
89.8% 
(82.2 to 93.6%) 
29.2% 
(23.7 to 35.0%) 
96.1% 
(89.9 to 99.0%) 
59.9% 
(41.0 to 72.9%) 
99.7% 
(99.2 to 99.9%) 
   Benin 
3,614 
(2,232-5,495) 
189.4 
(116.9-287.9) 
-61.5% 
(-77.8 to -35.8%) 
-302.7 
(-241.3 to -
355.6) 
89.1% 
(79.8 to 94.0%) 
31.2% 
(20.2 to 44.3%) 
96.5% 
(91.1 to 99.1%) 
55.4% 
(35.8 to 70.6%) 
99.7% 
(99.3 to 99.9%) 
   Burkina 
Faso 
7,517 
(4,875-11,033) 
201.4 
(130.6-295.5) 
-73.0% 
(-83.8 to -55.3%) 
-543.0 
(-386.3 to -
749.5) 
91.4% 
(84.3 to 95.4%) 
11.3% 
(5.6 to 19.7%) 
97.1% 
(92.5 to 99.3%) 
63.7% 
(45.4 to 76.5%) 
99.8% 
(99.6 to 100.0%) 
   Cameroon 
7,944 
(4,065-13,144) 
193.1 
(98.8-319.5) 
-68.9% 
(-81.8 to -51.6%) 
-427.1 
(-304.3 to -
566.3) 
84.1% 
(71.9 to 90.9%) 
11.4% 
(5.7 to 19.4%) 
96.1% 
(90.1 to 99.0%) 
64.3% 
(46.4 to 76.9%) 
99.5% 
(98.7 to 99.9%) 
   Cape Verde 
6 
(4-9) 
11.5 
(7.3-17.8) 
-96.5% 
(-98.0 to -93.9%) 
-314.0 
(-217.0 to -
430.9) 
70.9% 
(51.5 to 82.2%) 
31.4% 
(20.3 to 44.2%) 
92.6% 
(83.0 to 97.8%) 
58.8% 
(39.8 to 73.5%) 
98.2% 
(95.6 to 99.5%) 
   Chad 
20,057 
(14,653-26,592) 
654.3 
(478.0-867.5) 
-46.9% 
(-62.5 to -22.7%) 
-577.1 
(-381.3 to -
812.6) 
92.5% 
(86.5 to 95.8%) 
30.9% 
(20.1 to 44.7%) 
97.2% 
(92.4 to 99.3%) 
62.2% 
(43.3 to 75.3%) 
99.9% 
(99.6 to 100.0%) 
   Cote 
d'Ivoire 
7,608 
(4,839-11,201) 
196.5 
(125.0-289.4) 
-44.0% 
(-64.5 to -15.4%) 
-154.7 
(-135.0 to -
165.2) 
85.8% 
(73.5 to 92.4%) 
19.6% 
(11.4 to 29.6%) 
95.8% 
(89.6 to 98.8%) 
63.3% 
(46.5 to 76.4%) 
99.5% 
(98.7 to 99.9%) 
   The Gambia 
288 
(178-428) 
90.3 
(56.0-134.2) 
-63.1% 
(-77.1 to -44.0%) 
-154.6 
(-132.4 to -
173.2) 
88.8% 
(78.4 to 94.0%) 
2.8% 
(1.3 to 5.1%) 
95.9% 
(89.8 to 98.9%) 
54.5% 
(35.8 to 69.6%) 
99.7% 
(99.1 to 99.9%) 
   Ghana 
3,628 
(2,306-5,447) 
89.4 
(56.8-134.2) 
-79.0% 
(-87.7 to -63.5%) 
-336.8 
(-250.1 to -
434.5) 
85.0% 
(72.4 to 91.9%) 
7.7% 
(3.7 to 13.0%) 
96.3% 
(90.5 to 99.0%) 
58.0% 
(40.0 to 71.0%) 
99.6% 
(98.9 to 99.9%) 
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Location 
Name 
Deaths (95% 
UI) 
Mortality per 
100,000 (95% 
UI) 
Percent change 
in mortality rate 
1990-2017 (95% 
UI) 
Absolute 
difference in 
mortality rate 
1990-2017 (95% 
UI) 
Nutrition-
associated risks 
attributable 
fraction 
(95% UI) 
Low rotavirus 
vaccine 
attributable 
fraction  
(95% UI) 
Unsafe 
WASH 
attributable 
fraction  
(95% UI) 
Low ORS 
coverage 
attributable 
fraction 
(95% UI) 
Total risk 
attributable 
fraction 
(95% UI) 
   Guinea 
2,763 
(1,775-4,048) 
140.5 
(90.3-205.9) 
-72.1% 
(-83.2 to -53.8%) 
-362.6 
(-265.3 to -
471.9) 
87.0% 
(76.3 to 92.9%) 
31.1% 
(20.2 to 44.4%) 
96.8% 
(91.5 to 99.2%) 
58.4% 
(39.0 to 72.6%) 
99.7% 
(99.2 to 99.9%) 
   Guinea-
Bissau 
738 
(479-1,097) 
241.2 
(156.5-358.3) 
-64.5% 
(-78.2 to -39.2%) 
-438.3 
(-285.2 to -
582.9) 
85.5% 
(73.3 to 91.8%) 
17.6% 
(9.0 to 29.7%) 
96.8% 
(91.6 to 99.2%) 
62.6% 
(44.9 to 75.6%) 
99.6% 
(99.0 to 99.9%) 
   Liberia 
1,195 
(628-1,959) 
169.0 
(88.7-277.0) 
-85.0% 
(-92.5 to -72.5%) 
-960.4 
(-750.5 to -
1,158.5) 
84.8% 
(71.8 to 91.9%) 
18.7% 
(10.2 to 30.1%) 
96.9% 
(91.8 to 99.2%) 
49.4% 
(30.7 to 66.1%) 
99.6% 
(98.9 to 99.9%) 
   Mali 
8,704 
(5,093-13,707) 
233.0 
(136.4-367.0) 
-77.3% 
(-86.8 to -62.6%) 
-794.2 
(-593.7 to -
961.6) 
88.5% 
(79.1 to 93.7%) 
6.6% 
(4.3 to 9.2%) 
96.8% 
(91.6 to 99.2%) 
60.0% 
(42.2 to 73.9%) 
99.8% 
(99.4 to 100.0%) 
   Mauritania 
628 
(357-978) 
109.7 
(62.4-171.0) 
-83.4% 
(-90.2 to -73.0%) 
-551.9 
(-401.8 to -
699.0) 
92.0% 
(86.3 to 95.8%) 
13.3% 
(6.1 to 22.7%) 
95.8% 
(89.6 to 98.9%) 
62.7% 
(45.5 to 75.8%) 
99.9% 
(99.7 to 100.0%) 
   Niger 
16,939 
(11,091-24,281) 
387.8 
(253.9-555.9) 
-77.6% 
(-86.6 to -64.3%) 
-1,344.2 
(-969.9 to -
1,735.1) 
93.5% 
(88.0 to 96.5%) 
16.0% 
(11.4 to 21.2%) 
97.1% 
(92.2 to 99.3%) 
57.8% 
(40.5 to 72.3%) 
99.9% 
(99.7 to 100.0%) 
   Nigeria 
104,267 
(75,975-
139,594) 
302.7 
(220.6-405.3) 
-72.2% 
(-81.6 to -56.2%) 
-785.2 
(-517.5 to -
1,053.9) 
89.8% 
(81.9 to 93.9%) 
40.4% 
(35.3 to 45.1%) 
95.7% 
(88.8 to 98.9%) 
59.5% 
(40.8 to 73.1%) 
99.7% 
(99.1 to 99.9%) 
   Sao Tome 
and Principe 
8 
(4-13) 
31.5 
(16.6-53.4) 
-92.1% 
(-96.0 to -85.1%) 
-368.5 
(-278.1 to -
454.5) 
84.3% 
(70.5 to 91.6%) 
6.6% 
(2.7 to 13.3%) 
92.7% 
(82.9 to 97.9%) 
55.3% 
(35.9 to 70.6%) 
99.1% 
(97.9 to 99.8%) 
   Senegal 
3,300 
(2,109-4,807) 
145.6 
(93.0-212.1) 
-79.2% 
(-87.2 to -68.3%) 
-554.3 
(-454.3 to -
645.8) 
87.0% 
(75.2 to 92.7%) 
6.4% 
(2.7 to 13.0%) 
94.4% 
(86.5 to 98.4%) 
63.4% 
(45.5 to 76.1%) 
99.4% 
(98.5 to 99.9%) 
   Sierra 
Leone 
2,430 
(1,467-3,705) 
203.4 
(122.8-310.0) 
-76.9% 
(-86.6 to -62.3%) 
-678.8 
(-534.4 to -
824.0) 
88.9% 
(78.9 to 94.3%) 
9.2% 
(3.8 to 17.7%) 
96.9% 
(91.7 to 99.2%) 
39.9% 
(21.7 to 57.3%) 
99.7% 
(99.3 to 99.9%) 
   Togo 
1,625 
(899-2,698) 
151.9 
(84.0-252.3) 
-75.7% 
(-84.9 to -62.1%) 
-473.9 
(-321.0 to -
654.4) 
87.0% 
(76.3 to 92.9%) 
12.6% 
(7.3 to 20.6%) 
96.6% 
(91.2 to 99.1%) 
65.0% 
(47.0 to 77.1%) 
99.7% 
(99.2 to 99.9%) 
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